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INTRODUCTION  
   Ayurveda, Unani and Allopathy use several plant species to treat 
various ailments. The use of plant medicine is becoming trendy due to 
toxicity and side effects of allopathic medicines. This led to rapid increase in 
the number of herbal drug manufactures. Plant medicines, as the main 
remedy in traditional system of medicine have been used in health practices 
since ancient times. The practice continue today because of its biomedical 
benefits as well as takes place in cultural beliefs in many parts of world and 
have made a great contribution in maintaining human health . In India 
around 20,000 medicinal plant species have been recorded recently but 
more than 500 traditional communities use about 800 plant species for 
curing various diseases. Presently 80% of the world population depends on 
plant-derived medicine for primary health care for varied human diseases as 
it has no side effects. Plants are important sources of medicines and 
presently about 25% of pharmaceutical prescriptions in the United States 
contain at least one plant-derived ingredient. In the last century, nearly 121 
pharmaceutical products were formulated based on the traditional 
awareness obtained from various sources. 
HERBAL MEDICINES OBTAINED FROM PLANTS: 
India has one of the richest medicinal plant traditions in the world. 
They are estimated to be around 25,000 effective plant-based formulations, 
used in folk medicine and well- known to rural communities in India. There 
are more than 1.5 million practitioners of traditional medicinal system using 
medicinal plants in preventive, promotional and remedial applications. It is 
estimated that there are more than 7800 medicinal drug-manufacturing units 
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in India, which consume about 2000 tonnes of herbs annually. 
Medicinal plants play an essential role in the progress of effective 
therapeutic agents. During 1950 nearly 100 plants derived new drugs were 
introduced in the USA drug market including deserpidine , reserpine, 
vinblastine  and  vincristine which are derived from higher plants. From 
1971 to 1990 recent drugs such as ectoposide, teniposide, plaunotol, 
artemisinin and ginkgolides appeared all over the world. Many drugs were 
introduced from 1991 to 1996 including toptecan, gomishin, irinotecan etc. 
Plant based drugs provide exceptional contribution to contemporary 
therapeutics; for example: serpentine isolated from the root of Indian plant 
Rauwolfia serpentina in 1950’s, was a remarkable event in the management 
of hypertension and lowering of blood pressure. Vinblastine isolated from 
the Catharanthus rosesus is used for the treatment of choriocarcinoma, 
non-hodgkins lymphomas, leukemia in children, testicular and neck cancer. 
Vincristine is suggested for acute lymphocytic leukemia in childhood and in 
advanced stages of Hodgkins, lymophosarcoma, cervical and breast 
cancer. Podophyllotoxin is a constituent of Phodophyllum emodi presently 
used against testicular, small cell lung cancer and lymphomas. Plant based 
drugs are used to  cure mental illness, skin diseases, tuberculosis, 
diabetes, Jaundice, hypertension and cancer. Medicinal plants play a 
significant role in the development of potent therapeutic agents. They came 
into use in the modern medicine through the use of plants, as native cure in 
folklore medicine. More than 64 plants have been found to possess 
antibacterial properties; and more than 24 plants have been found to 
possess antidiabetic properties. Venom neutralization is effected by lupeol 
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acetate isolated from the root extract of Indian sarsaparilla Hemidesmus 
indicus. 
MARKET POTENTIAL OF MEDICINAL PLANTS: 
The market for ayurvedic medicines is found to be increasing at 25% 
annually. Sales of medicinal plants have grown by nearly 20% in India in 
past ten years (1987-96), the highest rate of growth in the world. But the per 
capital overheads in India on medicines per annum is amongest the lowest 
in the world. In other developing countries too, plants are the main source of 
medicine. Two of the largest users of medicinal plants are China and India. 
Traditional Chinese Medicine accounts over 5000 plant species; India 
accounts about 7000. According to Export Import Bank, the international 
market for Medicinal plant linked trade having a growth rate of nearly 7% 
per annum. China’s share in world herbal market is US$ 6 billion while 
India’s share is only US$1 billion. The annual export of medicinal plants 
from India is valued at Rs. 1200 million. 
 All the major plant-based pharmaceutical companies are showing a 
constant growth of about 15 per cent. Traditional medicine has served as a 
tool of alternative medicine, new pharmaceuticals, and healthcare products. 
Medicinal plants are important for pharmacological research and drug 
development, not only when plant constituents are used directly as 
therapeutic agents, but also as starting materials for the synthesis of drugs 
or as models for pharmacologically active compounds. A significant number 
of modern pharmaceutical drugs are derived from medicinal plants. The 
derivatives of medicinal plants are non-narcotic with little or no side effects. 
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FUTURE OF MEDICINAL PLANTS MARKET: 
According to WHO about 25% of modern medicines are descended 
from plants first used traditionally. Many others are synthetic analogues built 
on prototype compounds isolated from plants. Almost, 70% modern 
medicines in India are derived from natural products. The basic uses of plants 
in medicine will continue in the future, as a source of therapeutic agents, and 
as raw material base for the extraction of semi-synthetic chemical 
compounds such as cosmetics, perfumes and food industries. Popularity of 
healthcare plant- based products has been traced to their increasing 
acceptance and use in the cosmetic industry as well as to increasing public 
costs in the daily maintanance of personal health and well being. In the dual 
role as a source of healthcare and income, medicinal plants make an 
important contribution to the larger development process. Though the efficacy 
of plants requires development of quality consciousness in respect of the 
evaluation related evidences, supplying the demand for botanicals and 
herbals is a booming business. Recently, even developed countries are using 
medicinal systems that involve the use of plant drugs and remedies. 
Undoubtedly the demand for plant derived products has increased worldwide. 
The demand is estimated to grow in the years to come fuelled by the growth 
of sales of herbal supplements and remedies. This means that scientists, 
doctors and pharmaceutical companies will be looking at countries like China, 
India, etc. for their requirements, as they have the most number of medicinal 
plant species and are the top exporters of medicinal plants. 
 
 
CHAPTER I                                                                  INTRODUCTION  
DEPARTMENT OF PHARMACOGNOSY, COP, MMC, MADURAI. Page 5  
CURRENT REGULATIONS  FOR  STANDARDIZATION  OF  CRUDE  
DRUGS: 
        In recent years there is a surge in the interest regarding survival of 
Ayurvedic forms of medication. In the global perspective, there is a shift 
towards the use of medicine of plant origin, as the dangers and the short 
coming of modern medicine have started getting more apparent, majority of 
Ayurvedic formulation are prepared from herbs.  It is the cardinal 
responsibility of the regulatory authorities to ensure that the consumers get 
the medication, which guarantee with purity, safety, potency and efficacy. 
The quality control of crude drugs and herbal formulations is of vital 
importance in justifying their acceptability in modern system of medicine. But 
one of the major problems faced by the plant drug industry is non availability 
of rigid quality control profile for plant material and their formulations. Patent 
proprietary Ayurvedic medicines are sold over the counter in pharmacies. 
These products appear to represent a major share of branded traditional 
medicine in India. Nevertheless systems like Ayurveda still need to gain an 
empirical support of modern medical sciences to make them reliable and 
acceptable for all. An innovative research effort to define the advantage of 
traditional system of medicine with respect to their safety and efficacy could 
result in a better utilization of these corresponding systems of medicine. 
Internationally several pharmacopoeias have provided monographs stating 
parameter and  
 
Standard of many herbs Several pharmacopoeias like: 
• Chinese Herbal Pharmacopoeia 
• United States Herbal Pharmacopoeia 
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•  British Herbal Pharmacopoeia 
•  British Herbal Compendium 
•  Japanese Standards for Herbal Medicine 
•  The Ayurvedic Pharmacopoeia of India(API) and some product made 
out of these herbs.  
These Pharmacopoeia’s lay down monograph for herbs and herbal 
products to maintain their quality in their respective nations. Government of 
India too has brought out Ayurvedic Pharmacopoeia of India, which 
recommends basic quality parameters for eighty common Ayurvedic herbal 
drugs. 
 
FUTURE RESEARCH OF TRIBAL MEDICINES: 
Tribal healers in most of the countries, where ethnomedical treatment 
is frequently used to treat cut wounds, skin infection, swelling, aging, mental 
illness, cancer, asthma, diabetes, jaundice, scabies, eczema, venereal 
diseases, snakebite and gastric ulcer, provide instructions to local people as 
how to prepare medicine from herbal. They keep no records and the 
information is mainly passed on verbally from generation to generation. World 
Health Organization (WHO) has shown great interest in documenting the use 
of medicinal plants used by tribals from different parts of the world. Many 
developing countries have intensified their efforts in documenting the 
ethnomedical data on medicinal plants. Research to find out scientific 
evidence for claims by tribal healers on Indian herbs has been intensified. 
Once these local ethnomedical preparations are scientifically evaluated and 
disseminated properly, people will be better informed regarding                 
efficacious drug treatment and improved health status (Verma. S and                     
Singh.S.P, 2008). 
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HERBAL MEDICINES AND VARIOUS DISEASES: 
Herbal medicine is used to treat several conditions, such as 
allergies, asthma, eczema, premenstrual syndrome, rheumatoid arthritis, 
fibromyalgia, migraine, menopausal symptoms, chronic fatigue, irritable 
bowel syndrome, and cancer. 
Some herbs and their significance are detailed below; 
 Ginkgo (Ginkgo biloba) has been used traditionally to treat circulatory 
disorders and enhance memory. Even though not all studies agree, 
ginkgo may be chiefly effective in treating dementia (including 
Alzheimer disease) and intermittent claudication (poor circulation in the 
legs).   It also shows assurance for enhancing memory in older adults. 
Laboratory studies have revealed that ginkgo improves blood 
circulation by dilating blood vessels and reducing the stickiness of 
blood platelets. 
 Kava kava (Piper methysticum) is said to elevate mood, enhance well 
being and contentment, and produce a feeling of relaxation. Numerous 
studies show that kava may help treat anxiety, insomnia, and related 
nervous disorders. However, there is serious concern that kava may 
cause liver damage. 
 Saw palmetto (Serenoa repens) is used for the treatment of benign 
prostatic hyperplasia (BPH), a non-cancerous enlargement of the 
prostate gland. Several studies recommend that the herb is effective for 
treating symptoms, including frequent urination, having trouble starting 
or maintaining urination, and needing to urinate during the night. 
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 St. John's wort (Hypericum perforatum) is well suited for its anti-
depressant effects. 
 Valerian (Valeriana officinalis) is a popular substitute to commonly 
prescribed medications for sleep problems because it is considered to 
be both safe and gentle. 
 Echinacea preparations(from Echinacea  purpurea and other 
Echinacea species) may progress the body's natural immunity                       
(Bent S, 2008). 
 
CARDIOVASCULAR DISEASES: 
Cardio metabolic syndrome is related with multiple risk factors 
including insulin resistance, dyslipidemia, hypertension, and obesity. 
According to World Health Organization, every year about 2.8 million people 
die worldwide due to overweight or obesity. Occurrence of diabetes appears 
with projections to affect about 439 million adults by 2030, whereas 
cardiovascular diseases account for 30% of deaths annually, including both 
developed and developing countries. Because of their chronic degenerative 
nature, cardio metabolic-related disorders have long-lasting treatments, 
costly for both the patient and the health services, in addition to potentially 
harmful side effects caused by polytherapeutic regimens. In this context, 
herbal medicines have become the major source of bioactive molecules and 
emerged as potential therapeutic tools to fulfil a multiple-target strategy, 
especially because of their inherent large-scale structural diversity as 
compared with synthetic compounds (Chagas V.T.et al., 2015). 
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ZEBRAFISH, AS MODEL ORGANISM: 
 The zebrafish (Danio rerio) is a tropical freshwater species 
belonging to the minnow family (Cyprinidae) of the order Cypriniformes. The 
zebra fish is also a significant and extensively used vertebrate model 
organism in scientific research, and was the first vertebrates to be cloned. It 
is particularly notable for its regenerative abilities and has been modified by 
researchers to fabricate many transgenic strains  
 
The main advantages of zebra fish embryos in drug testing and 
discovery are summarized as follows: 
 Zebra fish and mammals demonstrate a high degree of similarity as it 
relates to molecular mechanisms of development and cellular 
physiology. 
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 Fertilization and development occurs externally, providing direct 
observation and manipulation of embryos in a wide range of laboratory 
conditions. 
 The small sized embryos (0.1 mm in diameter) allows for distribution into 
96 or 384- microtitre  well plates. A single embryo can be maintained in 
100 µl of embryo medium for days. 
 A pair of zebra fish can produce 100–300 embryos. The high number of 
zebra fish progeny per clutch facilitates statistically considerable sample 
sizes at minimal cost and makes the zebra fish an excellent model for 
medium- and, possibly, high- throughput chemical screening required for 
preclinical drug discovery and toxicological evaluation. 
 Embryonic development is rapid. For instance, embryos execute elusive 
maneuvers upon touch within 24 h post fertilization (hpf). Additionally, 
most major organs including the gut and the vasculature are in place by 2 
days post fertilization and embryogenesis is complete 5 days after 
fertilization. 
 Zebra fish embryos and early adults are optically transparent, a feature 
that facilitates direct observation of internal organs by light microscopy. 
 During organogenesis, zebra fish embryos are permeable to small 
molecules and drugs, providing easy access for drug administration and 
vital dye staining. 
 
ZEBRAFISH FOR CARDIOVASCULAR DISEASES: 
Cardio vascular diseases remain a primary cause of morbidity and 
mortality, and many of these diseases arise from genetic defects that affect 
the development and maturation of the heart. Hence, understanding the 
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genetic, molecular, and cellular mechanisms that govern the formation, 
differentiation, and growth of the heart will greatly augment our 
understanding of heart disease and aid the identification of new approaches 
to repair or regenerate damaged heart muscle. 
The advent of various genetic and cell biological tools such as 
forward genetic screens, transgenesis, lineage tracing, and cell 
transplantation, emerges the zebra fish, as a powerful vertebrate model to 
investigate a variety of biological processes. In addition, the zebra fish 
provides several advantages as a model to study cardiac development. First, 
the external development of the embryos permits a direct non invasive 
observation of the development of the heart as it happens and at cellular 
resolution. Secondly, zebra fish embryos do not initially rely on their 
cardiovascular system for oxygen needs. Therefore, zebra fish cardiac 
mutants can survive and continue to grow for several days, allowing a 
detailed analysis of their phenotype. Even though the zebra fish heart is 
simple in structure than its mammalian counterpart, genes responsible for 
essential steps of cardiac development are preserved throughout 
vertebrates (Shin J.T. et al., 2010). 
 
REASON FOR SELECTION OF Commiphora caudata (Wt&Arn) Engl: 
        Burseraceae family comprises about 17-19 genera and 540 species-
rich  genus of  flowering  plants in the frankincense and myrrh family, The 
genus contains approximately 190 species of shrubs and trees, which are 
distributed throughout the (sub-) tropical regions of Africa, the western Indian 
Ocean islands, the Arabian Peninsula, India, and Vietnam. The genus is 
drought-tolerant and common throughout the xerophytic scrub, seasonally 
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dry tropical forests and woodlands of these regions. The common 
name myrrh refers to several species of the genus, from which aromatic 
resins are derived for various fragrance and medicinal uses by humans with 
deserving attention to Commiphora caudata  (Wt&Arn) Engl. (Syn: Proteum 
caudatum, Balsamodendrum caudatum), which has been used in the 
treatment of numerous diseases, especially as analgesic, anti-inflammatory 
and wound healing  but more often valued for the aromatic resins. 
C.caudata is a large tree native from Indian subcontinent. It is 
popularly known as  the hill mango or green commiphora, is the most 
abundant Asian species of Commiphora of flowering plants in the 
frankincense and myrrh family, Burseraceae  in India. 
Though there is a traditional and experimental evidence to support 
various claims and benefits of these plants still it needs proper evaluation 
and exploitation. 
C.caudata is a traditional medicinal plant which is used in the 
treatment of diabetes, ulcer, inflammation, diarrhea, spasms, fever, 
strangury, arthritis, obesity, fever  and mainly for the treatment of cuts and 
wounds, vitiated conditions of vata, pitta in siddha system of medicines and 
used as aphrodisiac, astringent. Analgesic, anti-inflammatory, antioxidant, 
hepatoprotective, diuretic, antidiabetic, antiulcer and antibacterial activities 
have been reported by researchers. 
Leaves of the plant used traditionally to treat painful and inflammatory 
conditions. Leaf juice is applied on wounds. The leaves are traditionally used 
in the treatment of rheumatism, ulcers, diarrhoea and dysentry, spasms, to 
improve digestion and to increase appetite. Analgesic, antioxidant, 
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antiarthritic, antihyperlipidemic, Stem and bark are traditionally used in the 
treatment of rheumatism, ulcers, diarrhoea.  A lotion prepared from the stem 
bark is used to treat skin conditions such as impetigo, eczema and shingles. 
The oleo gum resin of the tree is used as incense, carminative and to treat 
stomach troubles, wounds, hyperlipidemia, atherosclerosis, urinary 
infections, ascites, fistula, piles, swelling, ulcers, and pain. Snake bites and 
scorpion sting. The resin of the stem mixed with water to form mouthwashes 
to cure mouth ulcers. It was reported as astringent, antiseptic, aphrodisiac.  
C.caudata is known to possess wide range of medicinal properties, 
which have been ascribed to the presence of bioactive compounds in 
different parts of the plant like flavonoids, steroids (guggulsterones), 
triterpenoids, proteins, carbohydrates  and glycosides. 
Though there is a traditional and experimental evidence to support 
various claims and benefits of these plants still it needs proper evaluation 
and exploitation. 
 
Based on the above discussion we focus our study to utilize the vast 
economic potentiality, which can be fully established by its vast 
consumption. It is evident that there is a good level of experimental evidence 
to support claims and advantages of various medicinal herbs used in our 
traditional diet and medicines. In this view we selected the widely available 
plant Commiphora caudata (Wt & Arn) Engl. for our study. 
 
In India it is available it has been recorded in dry deciduous and scrub 
forests of  Tamilnadu, Karnataka, Kerala, Andra Pradesh and also in 
SriLanka . 
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This study aims to scientifically explore its important medicinal uses 
which have not been fully studied. These initiated us to investigate the 
leaves of this plant with strict scientific protocols. Review of literature 
showed lacunae exist in the pharmacognostic, phytochemical and 
pharmacological studies of C.caudata. 
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LITERATURE REVIEW 
TAXONAMIC HIERARCHY:      
CLASSIFICATION:                          
 (Anonymous,www.eol.org) 
Kingdom :    Plantae 
Phylum :                      Tracheophyta 
Class :                      Magnoliopsida 
Order :                      Sapindales  
Family :                      Burseraceae 
Genus :                      Commiphora 
Species :                      caudata  
 
PREFERRED SCIENTIFIC NAME: 
                                Commiphora caudata  (Wt & Arn) Engl. 
 
OTHER SCIENTIFIC NAMES 
Syn: Amyris acuminata Roxb.;  
Amyris serratifolia Rottl. ex A. W. Benn.;  
Balsamea caudata (Wight & Arn.) Engl.;  
Balsamodendrum caudatum (Wight & Arn.) March.;  
Balsamodendrum roxburghianum (Wight & Arn.) Wall. ex Voigt;  
Commiphora roxburghii (Wight & Arn.) Alston; 
Protionopsis caudata (Wight & Arn.) Bl.;  
 Protionopsis roxburghiana (Wight & Arn.) Bl.; 
 Protium caudatum Wight & Arn.;  
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PREFERRED COMMON NAMES:    
English: Hill mango 
               Green commiphora 
 
LOCAL COMMON NAMES: (Anonymus,www.eol.org) 
 
Languages  
 
 Vernacular Names 
  Kannada (6)  Assuraada, hasuvaara, kalmaavu, konda maavu, konda 
mugur, kondamavu 
 
  Tamil (13) Atakamikam, atakamikamaram, karpurakkiluvai, 
kattukkiluvai, kiluvai, malaikkiluvai, malaima, malankiluvai, 
paccaikkiluvai , perunkiluvai, urukkutanaiparpamakki, 
venkiluvai, vetkiluvai 
 
 Telugu (7)  Konda-mamidi, kondamaamidi, kondamukkadi, kondaraavi, 
netta maamidi, vaetapathri, vetapatri (for balsamodendron) 
Sanskrit  (2) Ikkata, Ikkada  
Malayalam(2) Idinjil, Itinjil  
 
ORIGIN AND DISTRIBUTION: 
RANGE:  
           This species is has a restricted global distribution occurring only in 
India and Sri Lanka. Within India  mainly Southern India, it has been 
recorded in dry deciduous and scrub forests of Andhra Pradesh,  Karnataka,  
Kerala and Tamil Nadu.  
          Average income, frequency of cuttings and average pole length of live 
fences  were produced from the trees  Commiphora caudata which  is 
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traditionally called  as  “Kiluvai”  and  highly contributed to income from live 
fence of the homegardens in sites. Income of the live fence was mainly 
generated by sales of pole or stick after pollarding the trees. Thus, when 
planted by farmers, live fences tend to be simple linear. 
          The tree is sometimes harvested from the wild for local medicinal use. 
It is occasionally used as an avenue tree and is often planted as an 
ornamental. 
        Special characters:High durability, low  wind susceptibility, low 
susceptibility to pests, low  wood quality. 
GROWTH REQUIREMENT: 
1.SOIL: 
         Requires a in a well-drained soil with rich in organic matter. 
2.CLIMATE: 
        C.caudata  usually  growing  in the  full  sun or  sunny  position  on  hilly  
granite  rock  outcrops  in  dry  zone  areas.  
3.ALTITUDE: 
         The altitude is an important factor which limits the distribution  and 
importance of several species Among the medicinal plants, the species 
Commiphora caudata, are considered to be ecologically well established in 
the low hills of many places  of  Southern India  ( 450m above  msl  and 
750m above msl and 950m above msl ).  
Commiphora caudata is  also  found  in dry deciduous forest  from  the coast  
up to 1000-1200 meters  in the hills. 
         The medicinal species were respectively determined as ecologically 
important due to their high perpetuation level. 
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         The variation in local climate at different altitudes may cause this  
difference in structural organization  of  communities .           
 4. NUTRIENTS: 
           The soils are rich in organic matter, which increases content with 
increase in altitude. 
           Maximum value of organic matter has been found in  Commiphora 
caudata, organic matter also leads to increase in cation exchangeable 
capacity and quantity of N,K and P. P availability is also indicative of the soil 
pH. High level of P has been found in soil  having C.caudata plant. 
         There are trace elements that are required in micro-quantity for 
optimum growth of plants. C.caudata requires the amount of micronutrients 
in the order of Mn > Fe > Cu > Zn.. 
  Flowering season : From March to May. 
  Fruiting season    : From August to January. 
 Seeding season     : From August to January. 
  Leaves falling       : During the hot season. 
  Sex distribution: 
Commiphora caudata is bisexual (each flower of each individual has both 
male and female structures). 
  Mode of pollination : 
Commiphora caudata is pollinated by a wide variety of insects. 
  Seed dispersal : 
The seeds of Commiphora caudata are mainly dispersed by frugivorous 
birds and mammals. 
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PROPAGATION: 
Seed  and Cuttings.  Cutting propagation  is a very easy technique 
plantings of sticks or poles of trees (usually of only a major species) that are 
evenly spaced and periodically pollarded and trimmed. 
PLANT COLLECTION AND  AUTHENTICATION: 
Leaves of the plant C.caudata  selected for our study was collected 
from Oricheri Village,Bhavani Taluk, Erode District, Tamilnadu, India 
during the month of July 2016 and was authenticated by Dr.Stephen, 
Department of Botany, American college, Madurai and Dr.Sasikala, Director 
(Retd) of Siddha Central  Research Institute, Arumbakkam, Chennai. 
LEAF DRYING AND PULVERIZING: 
The leaves were collected and shade dried. It was powdered in a 
mixer. The powder was sieved in a No.60 sieve and kept in a well closed 
container in a dry place. 
WHOLE PLANT 
ETHNOMEDICAL USES: 
 Commiphora  caudata  (Common name:Kiluvai) is a traditional medicinal 
plant which is used in the treatment  of  diabetes,  ulcer,  inflammation , 
diarrhoea  and  spasms. (Selvamani P et al.,2013) 
 C.  caudata was practiced as village folklore medicine for treating ulcer, 
inflammation,  diarrhea  and  spasms.( Deepa V S et al.,2009) 
 The plant Commiphora caudata  posses astringent,  sweet,  cooling,  
aphrodisiac,  diuretic and antidiabetic activities. The C.caudata is used for 
fever, strangury , vitiated conditions of vata and pitta in siddha system of 
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medicines. C.caudata is a potential medicinal plant  used traditionally in the  
treatment  of  rheumatism , ulcers , diarrhoea  and diabetes.(Nisha P and 
Jyothi H.,2014) 
 C.caudata  employed in the treatment of  various ulcers .(Ganesan S et 
al.,2008) 
 Ethnomedical plants used for the treatment of cuts and wounds by Kurkuma 
tribes, Wayanadu district  of  Kerala, India. (Thom as B et al.,2014) 
 Many of these compounds have been used in the treatment of 
hyperlipidemia, rheumatic disorders, obesity and ischaemic heart diseases. 
C.caudata has been used traditionally in the treatment of arthritis , diabetes 
and obesity.(Geetha K and Ganapathy S.,2013) 
 Commiphora  wightii reported as endemic and endangered (Prasad M N V et 
al.,2007) 
 Analgesic, anti-inflammatory and antioxidant, hepatoprotective, diuretic, 
antiulcer and antibacterial activities were reported from this plant(Geetha K 
and Ganapathy S.,2013) 
PHYTOCHEMISTRY: 
 An exhaustive literature survey on the Commiphora species revealed that 
the genus is a rich source of steroidal compounds, flavanoids, glycosides 
phenolics, etc.,(Selvamani P et al.,2013) 
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LEAVES 
PHARMACOGNOSY: 
Macroscopy: 
Leaves were compound, alternative 3 to 7 foliolate, upper surface dark 
green, lower surface light green in colour. There is no characteristic odour 
and it has mucilaginous taste. Shape is ovate -oblong, length - 4.5 to 6.5 cm; 
width -2.2 to 3.5 cm; acuminate apex , slightly asymmetric base;  entire 
margin,  reticulate pinnate venation; pedicle length - 3.5 to 6.2 cm and 
glabrous texture , glossy above, subglaucous below. Leaflets  ovate or 
elliptical, chartaceous  and glabrous. 
Microscopy of the leaves: 
Leaflet Diagnostic features 
The leaflets  were dorsiventral with prominent midrib.  
Leaflets - dorsiventral, mesomorphic,hypostomatic, glaborous; midrib 
adaxially projecting into a hump;adaxial part shallowly convex.  
Vascular bundles of the midrib include one larger median bundle and one 
smaller, adaxial accessory bundle.  
 Lamina with uniserrate epidermal layers; mesophyll differentiated into a 
single layer of palisade cells and lobed aerenchymatous spongy 
parenchyma cells.  
Vascular bundle of the lateral vein  has adaxial bundle sheath extension. 
Stomata actinocytic type; epidermal cells angular, straight and thick 
walled.Vein islets polygonal; vein termination branched many times.  
The petiole is roughly circular in outline , petiole semicircular with adaxial 
depression.  
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Vascular strengths of the petiole many, arranged in a circle with adaxial 
opening. Petiole circular with a ring of vascular strands. 
 Secretory canals occur in the phloem region of leaf, veins and petioles. 
Large druses of calcium oxalate crystals abundant in the leaf. 
ETHNOMEDICAL USES: 
 Leaves of the plant used traditionally and tribal medicine of Kerala to 
treat painful and inflammatory conditions.The hill Pulayas of Kerala use 
the leaves to treat inflammation and pain.(Annu W et al.,2010) 
 Leaf juice is applied on wounds (Thomas B et al.,2014) 
 The leaves are useful in rheumatalgia (Nisha P,Jyoti H.,2014) 
 The leaves are traditionally used in the treatment of rheumatism, ulcers, 
diarrhoea  and spasms(Geetha K et al.,2014) 
 The leaves are used to improve digestion and to increase appetite 
(Akhade MS et al.,2017) 
 Leaves are used in the treatment of dysentry.(Gunasekaran M , 
Balasubramaniyam P.,2012) 
 
PHYTOCHEMISTRY: 
 It was identified that the active constituents present in the plant was 
steroids and triterpenoides and it was suggested as marker for this 
plant.(Akhade MS et al.,2017) 
 TLC of methanolic  C.caudata leaves:  
On pre-coated silicagel G60-F254 using the petroleum ether:Ethyl 
acetate : methanol in ratio 6:2:0.5 as mobile phase and E-
Guggulsterone as standard. The λmax of E-guggulsterone is identified 
as242 nm.HPLC analysis was done using PDA detector so that the 
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same system can be used to quantify the steroid or triterpenoid 
compounds having different absorption,the percentage content of E-
guggulsterone 0.059%  .(Akhade MS et al.,2017) 
 The leaves were reported to contain tannins, carbohydrates and oleo-gum 
resin.(Nisha P  et al.,2014) 
 The HCl extract of  C.caudata leaves contains alkaloids, glycosides, 
flavanoids, saponins, carbohydrates. The H2SO4 extract of the C.caudata 
leaves contains alkaloids, terpenoids and carbohydrates, phenols, proteins 
(abundent).(Aejitha S et al.,2015) 
 Phytochemical screening of C.caudata  showed the presence of 
glycosides, flavonoids, starch, reducing sugars, proteins, aminoacids, 
steroids, tannins and terpenoids . (Selvamani P et al.,2013) 
 The presence of flavonoids, tannins , polyphenols , alkaloids , terpenoids  
were reported ( Meera S and Yashashwini Y C .,2016) 
 Phytochemical studies of this plant showed the presence of flavonoids, 
glycosides, steroids, proteins, mucilage, tannins, terpenoids, and 
carbohydrates .(Geetha K and Ganapathy S, 2013) 
 The potential activity of the extracts can be attributed to the presence of 
antioxidant principles such such as phenolic compounds which were  
reported from this plant.(Geetha K,Ganapathy S.,2013) 
 The  percentage yield of ethanolic extract  was 8%w/w. The amount of 
phenols in ethanolic extract of C.caudata was found to be 18.67mg/g of 
crude drug. (Geetha K and Ganapathy S, 2013) 
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 Phytochemical study showed the presence of flavanoid compounds as a 
secondary metabolite in plants which is well known for its anti-
inflammatory property.(Balasundar S et al.,2016) 
PHARMACOLOGICAL ACTIVITIES: 
 Hepatoprotective   activity was reported for C.caudata leaves (Selvamani 
P et al.,2013) 
 Pharmacological evidence  reports  that  C.caudata  have antidiabetic, 
antimicrobial, antibacterial and anticancer activities. (Selvamani P et al., 
2013) 
 EFFECT ON NERVOUS SYSTEM: 
It was demonstrated that C. caudata leaves was effective in reverting 
amnesia in scopolamine induced amnesia in rats(200,400mg B.W p.o) 
learning and memory enhancing activity was also proved dose 
dependently (Meera S and Yashashwini Y C.,2016) 
 ANTIMALARIAL ACTIVITY: 
Invitro schizonticidal activity with P.falciparum (Prasad M N V et al.,2007) 
 ANALGESIC EFFECT: 
IP injection of extract(250,500 mg ) significantly inhibited acetic acid 
induced writhing response in mice 73.44% and 77% respectively when 
compared to aspirin 25mg/kg ,92.18%.(Annu W et al.,2009) 
 ANTIOXIDANT ACTIVITY: 
 Reduction in lipid peroxidation , increase of superoxide  dismutase  
activity in brain homogenate , catalase activity, glutathione assay dose 
dependent manner proved its  antioxidant effect . (Meera S and 
Yashashwini Y C.,2016) 
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 All the invitro  assays  of the ethanolic extract of the C.caudata leaves 
showed antioxidant activity by ability to scavenge free radicles. This 
study showed that C.caudata has potent antioxidant activity than C.Var 
pubescence (Deepa V S et al.,2009)  
 The C.caudata posses higher antioxidant activity than C.var  
pubescence which may correlatable to the phenolic and flavanoid 
content of the respective plant extract. (Deepa V S et al.,2009). 
 The antioxidant studies on the ethanolic extract of Commiphora species 
could be  helpful in preventing or slowing the progress of various 
oxidative stress-related diseases (Deepa V S et al.,2009). 
 Invitro  antioxidant effect of ethanolic extract of leaves by anti- lipid 
peroxidation  method showed total inhibition of  FeCl2 to ascorbic acid 
stimulated rat liver peroxidation  at 50 µg/ml did not significantly increase 
the anti lipid peroxidation any further. From the above findings it was 
reported that C.caudata leaves has potent analgesic and anti 
inflammatory activity  and justifice its use in traditional medicine to treat 
inflammatory and painful conditions and may be due to free radical 
scavenging activity.  (Annu W et.al.,2010) 
 ANTIARTHRITIC ACTIVITY: 
The ethanolic extract of C.caudata leaves was reported that the anti 
arthritic activity by complete Freunds adjuvant induced arthritic rats (200 
and 400 mg/kg P.O). The  ethanolic  extract of C.caudata leaves  posses  
potential antiarthritic activity. (Girija P et al., 2014, Reddy J S et al., 2014) 
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 ANTIHYPERLIPIDAEMIC ACTIVITY: 
 The ethanolic extract of C.caudata leaves showed significant 
antihyperlipidaemic  properties  and it can be used in the treatment of 
vascular disorders   including atherosclerosis (Geetha K and Ganapathy 
S.,2013)  
 In a dose dependent manner the oral administration of EECCL (100 and 
200 mg/kg body weight) for 21 days significantly lowered the serum total 
cholesterol(TC), triglycerides(TG)  and low density lipoprotein-(LDL-C) 
levels while a marked increase in high density lipoprotein(HDL-C) levels 
were observed . (Geetha K and Ganapathy S.,2013) 
 The alcoholic (propanol) extract of C.caudata leaves significantly 
reduces the lipid accumulation with 51.5% at 100 µg/ml through the 
quantification method of Oil Red O staining.(Invitro Antiadipogenic 
activity). The ethanolic extract of the C. caudata leaves proved to be 
beneficial in the management of hyperlipidaemia. (Geetha K et.al,2014) 
 ANTIANAEMIC ACTIVITY: 
Ethanolic extract of C.caudata leaves  with dose 400 mg/kg, p.o 
significantly  increase the red bloodcells, haemoglobin and above the 
400 mg/kg dose significantly  decrease the white blood cells, erythrocyte 
sedimentation rate, SRF (Serum rheumatic factor) and CRP(c-reaction 
protein) when compared with arthritic control rats.(Girija P et.al,2017) 
 Hematological parameters: The ethanolic extract of C.caudata leaves 
(200mg/kg)treated group reduces the WBC and increases the 
haemoglobin content significantlt and no effect on RBC when compared 
with arthritic control.(Girija P et al.,2017) 
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 HEPATOPROTECTIVE ACTIVITY:  
The oral administration of ethanolic extract of C.caudata (200mg/kg)for 
21 days which  reduces the AST,ALT and ALP levels (were observed) 
which indicates the hepatoprotective potential of the extract.(Geetha K 
and Ganapathy S.,2013). 
 ACUTE TOXICITY  STUDIES: 
 The  acute toxicity studies in ethanolic extract of C.caudata leaves was 
carried out using Albino rats as per the guidelines set by Organization 
for Economic Co-operation and Development (OECD) received from 
Committee for the Purpose of Control and Supervision of Experiments 
on Animals (CPCSEA)}.The C.caudata at the dose of 2g/kg B.W was 
given to 5 animals.the animals were continuously observed  for 14 days 
for general behaviour and mortality. Mortality was not observed by the 
dose of 2 g/kg  bodyweight  of  C.caudata  leaves  in the oral toxicity 
studies. From the results the efficiency test drug doses of 0.2,0.4g/kg  
body weight  were chosen for the efficiency studies.(Girija P et.al,2017) 
 The ethanolic extract of C.caudata leaves was found to be less toxic. 
(CTC 50 ranging from120- 720 µg/ml) on 3T3 L1 cells. (Geetha K 
et.al,2014) 
 BEHAVIOURAL AND TOXIC  EFFECT: 
Ethanolic extract of the leaf given p.o  and observed behavioural 
changes,toxicity and mortality . LD 50 was greaterthan 1500 mg p.o in 
mice. (Annu W et.al.,2010) 
 ANTI INFLAMMATORY ACTIVITY: 
 The aqueous extract of C.caudata leaves has proved for its  significant 
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action in inflammation for oral administration is much better than 
external application in experimental evaluation on artificially induced 
inflammation. So it could be considered as a drug of choice for 
inflammatory conditions. (Balasundar S et.al,2016) 
 The ethanolic extract of  C.caudata leaves reduced the paw volume at 
41.52%, 45.76% in first phase. 62.33%, 65.35%   in second phase. 
(Selvamani P et.al,2013) 
 Ethanolic extract of the C.caudata leaves and its formulation when 
evaluated (C.caudata leaves-25mg,Commiphora berryi bark-25mg, 
Commiphora pubecense -25 mg =final 300 mg/capsule ) for CCl4 
induced hepatotoxicity in albino rats. It was observed that the 
percentage of hepatoprotective of C.caudata leaves was significant in 
cell necrosis, fatty change, hyaline regeneration, ballooning 
degeneration. (Balamurugan B et.al.,2010) 
 Histopathological studies of the liver showed preservation of the 
structural integrity of the hepatocellular membrane in a dose dependent 
manner. Formulation showed significant activity than the individual 
drugs. (Balamurugan B et al., 2010) 
 Ethanolic extract of the leaves showed inhibition of  carrageenan 
induced paw oedema in rats (250,500mg/kg) dose dependently (67 and 
78%).Indomethacin (5mg/kg) showed 89% inhibition.(Annu W et 
al.,2010) 
 The ethanolic extract of the C.caudata leaves inhibits the activation of β-
cells by medicinal constituents because it contains substantial amounts 
of plant steroids which are reported to produce an anti inflammatory 
action.(Girija P et al.,2017) 
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LEAF  OIL: 
PHYTOCHEMISTRY: 
 The yield of 2.7ml/kg from fresh leaves C.caudata was reported and by  
GC-MS analysis ,the presence of 15 compounds were reported. In which 
β-pinene(33.7%), cyclofenchene(17.8%), and α-terpineol (10.5%) were 
found to be major compounds. 10ml/kgaromatic oil with mango like odour 
volatile oil yield was reported . (Anjaneya Reddy et al.,2015) . 
 Monoterpene hydrocarbons (51.54%) i.e. cychlofenchene (17.84%) and 
β-pinene (33.70%) were the major compounds. 
 α-Terpineol (10.40%), verbenol (5.40%), 4-terpineol (3.79%), myrtenol 
(3.73%), myrtenal (3.45%), linalool acetate (2.61%), thujen-2-one 
(2.02%), β-linalool (1.48%), 2-pinene-4-one (1.37%) and 1,8-cineole 
(0.94%) were the oxygenated monoterpenes accounting for 35.19% of 
the oil. 
 Other compounds identified in the oil were: sesquiterepene 
hydrocarbons, caryophyllene (1.66%) and oxygenated sesquiterpenes 
(11.61%) , caryophyllene oxide (9.82%)  and ledol (1.79%).(Anjaneya 
Reddy et al.,2015)  
 28 compounds were reported by GC-MS in which verbenone(8.1%), 3-
carene(9.9%), cyclofenchene(16.9%), dihydrocarveol(19.5%) are major 
compouns.(Anjaneya Reddy et al.,2015) 
FRUIT: 
PHYTOCHEMISTRY: 
 It  was reported that phytochemical screening of the fruit using 3 
various solvents(Ethanol, Methanol and Aqueous) to  contain the following 
constituents. 
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Ethanol –alkaloids, coumarins, flavanoids, terpenoids, phenols, cardiac 
glycosides, saponins, quinones, steroids.  
Methanol-alkaloids, coumarins, flavanoids, terpenoids, phenols,cardiac 
glycosides, saponins, quinones, steroids. 
Aqueous-tannins, terpenoids, cardiac glycosides, quinones, 
steroids,carbohydrates. 
(Shaik A T and Balakumar B S.,2014) 
 FRUIT  OIL:  
PHYTOCHEMISTRY: 
 Monoterpene hydrocarbons (32.56) i.e.Cychlofenchene(16.97),  β-
Pinene(2.58 ) are the major compounds.  
 Linalool acetate (1.15),  Thujen-2-one (1.91),  Myrtenol (0.86),  β-Linalool 
(1.23),  1,8-Cineole (2.05)  were the oxygenated monoterpens (50.32).  
 3-Carene(9.90),  tert-Butylbenzene (1.11),  D-Limonene (0.89),  p-
Mentha-1,3,8-triene (1.11),  m-Cymene (2.62), Nonanal (0.91), 
Verbenone (8.18),  Phenylacetone (3.75),  2(10)-Pinene-3-ol (2.51),  cis-
p-Mentha-2,8-dienol (0.90), Melilotal(1.12),  α-Campholenal (1.00), 1-
Nonanol (1.20),  Dihydrocarveol (19.58 ) ,   p-Cymene-8-ol (6.05),  
Carveol (1.37),  1-Decanol (1.83), Capric acid (2.41),  oxygenated 
hydrocarbons (4.24),  aromatic compounds (8.67). 
 Oxygenated sesquiterpenes (0.96) ,  caryophyllene oxide (0.96).     
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SEEDS: 
ETHNOMEDICAL USES: 
 The endosperm obtained from 4/5 fresh or dried seeds of C.caudata is 
taken 2 times a day for 2-3 days to relieve stomach ache. (Vikneshwaran 
D et al.,2008)  
PHYTOCHEMICAL STUDIES: 
 By HPLC analysis acetonitrile: water (86:14) with Rt 6 mts for E-
guggulsterone with no interference with other constituents and found to 
be suitable for estimation of steroids and terpenoids using PDA 
actdetector. The percentage of E-guggulsterone present as 
0.059%.(Akhade MS et al.,2017) 
 The C.caudata plant extract contains 8.21± 5.0%(mg/ml) flavanoids, 
20.8 ±0.2% (mg/ml)phenol. ( Deepa V S et al.,2009) 
STEM AND BARK 
ETHNOMEDICAL USES: 
 The stem and bark are traditionally used in the treatment of  rheumatism, 
ulcers, diarrhoea and spasms.(Girija P et al., 2017) 
For Skin Diseases: 
 A lotion is prepared from its stembark is used to treat skin conditions 
such as impetigo, eczema and shingles.(Prasad MNV et al.,2007) 
 Bark is used in the treatment of diarrhoea (Gunasekaran 
M,Balasubramaniyam P) 
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ROOT: 
PHYTOCHEMISTRY: 
 It was reported that phytochemical screening of the root using various 
solvents. 
1. Aminoacids(Chloroform, Ethyl alcohol, Water) 
2. Anthraquinone(Absent in all solvents) 
3. flavanoids(Petroleumether, Chloroform, Ethanol, Water) 
4. glycosides(Petether, Chloroform, Ethylalcohol, Ethylacetate, Water) 
5. Proteins(Ethylalcohol, Ethylacetate) 
6. reducing sugars(Petether, Chloroform, Ethanol, Water) 
7. saponins(Water) 
8. starch(Petether, Chloroform, Ethyl acetate, Ethylalcohol, Water) 
9. tannins(Petether, Chloroform, Ethylalcohol, Water) 
10. terpenoids(Petether, Chloroform, Ethyl alcohol) 
11. steroids (Petether, Chloroform, Ethyl acetate, Ethanol, Water) 
12. (Nisha P and Jyoti H.,2014) 
 The percentage yield of extractive values of root were reported as  
Petroleum ether (brown)-0.9, Chloroform (brown)-1.2 
Ethyl acetate (brown)-1.17, Ethyl alcohol (brown)-9.7 
Distilled water (brown) - 4.7.(Nisha P and Jyoti H.,2014) 
PHARMACOLOGICAL ACTIVITY: 
HEPATOPROTECTIVE ACTIVITY 
 It was reported that 500µg/ml,40µg/ml protected antitubercular drugs and 
galactosamine hydrochloride induced hepatotoxicity in BRL3A Cell lines 
protection is 80.5%.(Nisha P and Jyoti H.,2014) 
 Invitro  hepatoprotective activity of ethanolic extract of C.caudata (wight & 
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Arn) Engl on the BRL 3A cell line study indicates that root extracts of 
plants have good potentials for use in hepatic diseases.(Nisha P and 
Jyothi H.,2014) 
BARK: 
Ethnomedical uses: 
 The  bark  is traditionally used in the treatment of  rheumatism, ulcers, 
diarrhoea and spasms.(Girija P et al.,2017) 
PHARMACOGNOSY: 
 The alcoholic extract of C.caudata bark was found to be.,19.5%w/w. 
     (Geetha K et al., 2014) 
GUM RESIN: 
ETHNOMEDICAL USES 
 The oleo gum resin of the tree is used as incense. 
     (Anonymus, 1950) 
 The gumresin from  the bark is used for treating stomach troubles. 
(Latha P et al.,2005) 
 The gum of the stem mixed with water to form mouthwashes to cure 
mouthulcers and the gum is used for wound healing.(Ganesan S et 
al.,2007) 
 Resin is carminative. (Akhade M S et al.,2017) 
PHYTOCHEMISTRY 
 Guggulsterone-M, Guggulsterols-I, Guggulstrols Y, myrrhanol, 
myrrhanone A,Z and E-guggulsterones many related compounds were 
ferulates, furanosesquiterpenes, steroids, oxygenated alkenes, 
lignans,etc.(Prasad M N V et al.,2007) 
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 PHARMACOLOGICAL ACTIVITY: 
ANTIOXIDANT ACTIVITY 
 The methanolic extract of the oleo gum resin showed NO (Nitric oxide) 
production inhibition.(Prasad M N V et al.,2007) 
 This plant contain a substance like guggulsterone, which has been 
proved to be anti-inflammatory by the mechanisms may be associated 
with the inhibition of inflammatory mediator overproduction. (100µg/ml of 
C.caudata  having 75.98% anti inflammatory activity compared to 
dexamethasone having 94.35% activity.)(Girija P et al.,2017) 
BARK  
PHARMACOLOGICAL ACTIVITY: 
HYPOGLYCAEMIC ACTIVITY: 
 Methanolic extract of C.caudata bark reduced blood glucose level by 
chronic treatment  in alloxan induced diabetic rats (dose  of 200,400 mg 
/kg B.W P.O)  in duration dependent manner which  indicating its 
antihyperglycaemic activity.Normoglycaemic blood level also not 
altered(normal rats) further strengthening the hypoglycaemic potential of 
that  extract. 
(Srinivasa Reddy  CH et al.,2017). 
 The C.caudata bark did not show the significant inhibition of fat 
accumulation or fat droplet formation at the tested 
concentration(100µg/ml-4.8%).(Geetha K et al.,2014) 
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ACUTE  TOXICITY STUDIES: 
 The dose of 2000mg/kg of methanolic extract of bark was found to be safe 
and no toxicity and mortality was not observed.(Srinivasa Reddy CH 
et.al,2017) 
ZEBRAFISH AND 3RS: 
Zebrafish research supports each of these principles through, 
REFINEMENT: Using the results of zebrafish screening to design definitive 
mammalian studies that will provide the useful information (e.g., collection of 
additional endpoints, shifting timing of studies in the drug development 
process) 
REPLACEMENT: Testing chemicals under REACH regulations in a non- 
mammalian model rather than rodents or rabbits 
REDUCTION: Reducing the number of compounds that need to be tested in 
mammalian models by facilitating the choice of candidates with a greater 
likelihood of success (River C,2014). 
ZEBRAFISH AN EXCELLENT MODEL ORGANISM: 
      The zebrafish is an excellent model organism for vertebrate 
developmental biology, which generates high-value knowledge on safety 
risks of novel drugs. The larval zebrafish possess advantages of whole 
organism phenotypic assays and those (rapid production of results with 
minimal resource engagement) of in vitro high-throughput screening 
techniques. 
     An attractive feature of zebrafish assays for pharmacological 
investigations is the potential to use of them in medium-to high- throughput 
screening mode, as they are smaller in size (5cm for an adult and 5mm for 7 
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days postfertilization (d.p.f.) larvae) and robust freshwater tropical cyprinid 
that is easy to maintain in large stocks due to their highfecundity. 
Experimental manipulation and direct observation of organ function can be 
easily performed as embryos are transparent and rapidly develop ex utero 
with most organs becoming fully functional between 3 and 5d.p.f. 
METHOD: 
 Treatment with a range of concentrations of the test compound (e.g., 0.1 
to 100μM) 
 Stock solution of test compound in either DMSO or an aqueous vehicle 
added to zebrafish embryo medium 
 Continuous exposure of zebrafish embryos/larvae in the treated embryo 
medium between approximately 4 and 120 hours post-fertilization 
(developmental periods generally analogous to the period of treatment in 
mammalian EFDstudies) 
 Assessment of viability, growth, morphology and functional end points 
 The results of these tests are then used for identification of potential 
developmental toxicity hazards, the data are used to predict whether the 
test compound is likely to produce any developmental toxicity in standard 
mammalian EFD studies or human exposures (River C, 2014). 
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ANATOMY OF ZEBRAFISH: 
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EMBRYONIC STAGES OF ZEBRAFISH: 
 
 
• The organization of the genome and the genetic pathways controlling 
signal transduction and development appear to be highly conserved 
between zebrafish and humans. 
• In contrast to rodents, the zebrafish larvae are not foetal but are closer 
to the juvenile state in that the nervous system is mature, vital organs 
are functioning and tissue architecture is fully developed at the time of 
theassays. 
• Further, only milligrams of compound are needed for screening in 96-
well plates as the larvae can live in as little as 50 ml of fluid. 
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• Finally, chemical screening is facilitated by the fact that zebrafish are 
reasonably tolerant to dimethylsulphoxide concentrations generally 
used in such technologies and small molecule compounds dissolved in 
the swimming medium can reach target tissues via passage through 
the skin of thelarvae. 
• The zebrafish cardiovascular system can reveal decrease in heart rate 
and atrial– ventricular dissociation, which may signal human ether-a-
go-go-related gene (hERG) channel blockade. 
• Another area of interest is the CNS, where zebrafish behavioural 
assays have been further developed into screening platforms for 
assessment of locomotor activity, convulsant and proconvulsant 
liability, cognitive impairment, drug dependence potential and impaired 
visual and auditoryfunctions. 
• Zebrafish also provide interesting possibilities for evaluating effects on 
bone density and gastrointestinal function. 
• In addition, available knowledge of the renal system in larval zebrafish 
can permit identification of potential safety issues of drugs on this often 
neglected area in early developmental stages (Barros T.P.et al;2008). 
 
ZEBRAFISH AS A TOOL FOR DEVELOPMENTAL TOXICITY ASSAY 
The 5th-day zebrafish developmental toxicity assay is based on well-
tested methods with demonstrated value in pharmaceutical and chemical 
compound screening. In addition, the assay has been designed to predict 
the outcome of standard developmental toxicity testing methods defined in 
guidance from the US FDA and ICH for pharmaceuticals and the US EPA 
and OECD for chemicals. 
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• potential to use of them in medium-to high- throughput screening mode, 
as they are smaller in size (5cm for an adult and 5mm for 7 days 
postfertilization (d.p.f.) larvae) and robust freshwater tropical cyprinid 
that is easy to maintain in large stocks due to their high fecundity. 
• Experimental manipulation and direct observation of organ function can 
be easily performed as embryos are transparent and rapidly develop ex 
utero with most organs becoming fully functional between 3 and 5d.p.f. 
• The organization of the genome and the genetic pathways controlling 
signal transduction and development appear to be highly conserved 
between zebrafish and humans. 
• In contrast to rodents, the zebrafish larvae are not foetal but are closer 
to the juvenile state in that the nervous system is mature, vital organs 
are functioning and tissue  architecture is fully developed at the time of 
the assays. 
• Further, only milligrams of compound are needed for screening in 96-
well plates as the larvae can live in as little as 50 ml of fluid. 
• Finally, chemical screening is facilitated by the fact that zebrafish are 
reasonably tolerant to dimethylsulphoxide concentrations generally used 
in such technologies and small molecule compounds dissolved in the 
swimming medium can reach target tissues via passage through the 
skin of the larvae. 
• The zebrafish cardiovascular system can reveal decrease in heart rate 
and atrial– ventricular dissociation, which may signal human ether-a-go-
go-related gene (hERG) channel blockade. 
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• Another area of interest is the CNS, where zebrafish behavioural assays 
have been further developed into screening platforms for assessment of 
locomotor activity, convulsant and proconvulsant liability, cognitive 
impairment, drug dependence potential and impaired visual and auditory 
functions. 
 
• Zebrafish also provide interesting possibilities for evaluating effects on 
bone density and gastrointestinal function. 
 
• In addition, available knowledge of the renal system in larval zebrafish 
can permit identification of potential safety issues of drugs on this often 
neglected area in early developmental stages (Barros T.P.et al;2008). 
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AIM AND OBJECTIVE 
Cardiovascular   diseases (CVD)   s   is   a   group   of   diseases   that   
involve   the heart and blood vessels. They are the major cause of death,  
globally an approximate million people died from CVDs in 2012, representing 
30% of all global deaths. Over three quarters of CVD deaths take place in low 
and middle-income countries. CVDs includes coronary   artery    diseases 
(CAD)    such    as angina and myocardial infarction, stroke, heart   failure, 
hypertensive    heart    disease, rheumatic    heart disease, cardiomyopathy, 
heart arrhythmia, congenital heart disease, valvular heart disease, carditis, 
aortic aneurysms, peripheral artery disease, thromboembolic  disease,  and 
venous thrombosis(Wikipedia). 
Doxorubicin (DOX) is a potent and extensively used anthracycline 
antibiotic for the treatment of cancers. However, the major impeding issue 
pertaining to the clinical application of DOX is related to its ability to induce 
untoward toxicity in heart tissues.  The occurrence of fatal cardio toxicity is 
characterized by an irreversible cardiomyopathy which compromises the 
clinical efficacy of DOX and accounts for the major basis of the chemotherapy 
related morbidity and mortality (Ojha et al., 2016). 
Since the origin of the human civilization, plants and herbs have been 
traditionally used in the treatment of various diseases and ailments. In this 
direction, the prospect of harnessing the potentials of plant-derived small 
molecules (Phytochemicals) are the natural constituents of herbs and plants. 
Nowadays, essential oils are well known for their cosmetic, 
pharmaceutical, agricultural and industrial applications. The main focus of 
pharmaceutical and agricultural companies in the Mediterranean countries is 
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now the commercial production of known aromatic herbs and neglecting the 
utilization of trees like Commiphora caudata(Wt & Arn) Engl., which are 
globally distributed and have massive diversity and may provide new sources 
of flavors, perfumes and remedies for aging as well as other medical and 
agricultural applications. 
AIM: 
To study the Pharmacognostical, preliminary phytochemical 
Perspectives of The Leaves ofCommiphora caudata. - Invivo Cardio 
protective Potential of Its steroid rich fraction on Doxorubicin induced Cardio 
toxicity in Zebra fish Larvae Model. 
OBJECTIVE: 
The objective of the study was divided into three parts. 
 
PART 1: PHRAMACOGNOSTICAL STUDY 
 Collection and authentication of plant 
 Morphological study of the plant 
 Microscopy of the leaf 
 Anatomical study using light microscope 
 SEM analysis 
 Powder microscopy 
 Microscopic schedules 
 Physio-chemicalparameters 
 Ash values 
 Loss on drying 
 Extractive values 
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PART 2: PRELIMINARY PHYTOCHEMICAL SCREENING 
 Qualitative analysis of the leaves for the presence of various 
phytoconstituents 
 Determination of flavonoid content, total phenolic content of the leaf, 
 Determination trace elements by SEM 
 Preparation of ethanolic extract of the leaves (EECCL) 
 To study the TLC of the EECCL 
 To study the HPTLC  profile of the EECCL to identify the presence of  
guggulsterone 
PART 3: PHARMACOLOGICAL STUDIES: 
The 3R’s ethical principle (Reduction, Refinement, and Replacement) 
was implemented that help to minimize harms to vertebrate animals used in 
science. 
 Collection of Danio rerio or zebra fish (Zf)Larvae 
 To study the preliminary toxicological studies of the EECCL on the 
early development of Zf 
1. Whole embryo culture toxicity study 
2. Larval toxicity study 
 Observation of the overt morphological effects of Doxorubicin on heart 
including ventricular collapse and pericardial edema. 
 Observation of blood cell circulation within tail blood vessels using high 
speed camera  
 To evaluate the action of EECCL  on  Doxorubicin induced toxicity of 
Zf larvae model like  heart fractional shortening measurement to 
assess heart rate and contractility.   
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CHAPTER IV 
MATERIALS AND METHODS- RESEARCH DESIGN 
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MATERIALS AND METHODS 
 
4.1. PLANT COLLECTION AND AUTHENTIFICATION 
Leaves of the plant C.caudata  selected for the study was collected 
from Oricheri, Bhavani (Tk), Erode (Dt), Tamilnadu, India during the month of 
July 2016 and was authenticated by Dr.Stephen, Department of Botany, 
American college, Madurai and Dr.Sasikala, Director (Retd) of Siddha Central 
Research Institute, Arumbakkam, Chennai. 
 
LEAF DRYING AND PULVERIZING 
The leaves were collected and shade dried. It was powdered in a mixer. 
The powder was sieved in a sieve No.60 and kept in a well closed container in 
a dry place. 
 
4.2. PHARMACOGNOSTICAL STUDIES 
Morphological and micro morphological examination and 
characterization of medicinal plants have always been accorded due 
credentials in the pharmacognostical studies. Botanical identity of the plants is 
an essential prerequisite for undertaking the analysis of medicinal properties 
of any plant. A researcher may succeed in getting a new compound or may 
find many useful pharmacological active properties in the plant. If the 
botanical identity of the plant happens to be dubious or erratic, the entire work 
on the plant becomes invalid. Thus it is needless to stress the botanical 
identity of the crude drug is the threshold in the processes of pharmacological 
investigations. The researchers should be equipped with all possible 
diagnostic parameters of the plant on which the researchers plan to work. 
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4.2.1 MORPHOLOGICAL STUDIES OF C.caudata: 
Leaf, bark, seed, fruit, and flower were studied individually for its 
morphological characters by organoleptic analysis. 
4.2.2 MICROSCOPICAL STUDIES ON THE LEAF OF C.caudata: 
COLLECTION OF SPECIMEN 
Care was taken to select healthy plants and for normal organs. Leaf, 
Petiole specimens were collected from a healthy plant by making a cut with 
petioles. The materials were cut into pieces and immediately immersed in 
fixative fluid FAA (Formalin – 5ml + Acetic acid – 5ml +70% Ethyl alcohol –
90ml). 
DEHYDRATION 
After 24 hours of fixing, the specimens were dehydrated with graded 
series of ethyl alcohol and tertiary-butyl alcohol (Sass, 1940). The specimen is 
then kept in various grades of the fluid for about 6 hrs. Every time the fluid is 
decanted and immediately the specimens were flooded with next grade of 
fluid. 
INFILTRATION WITH PARAFFIN WAX 
After dehydration, the shavings of paraffin wax were added to the vial 
containing the plant material with pure TBA. The paraffin shavings are added 
every 30mts at about 40-45ºC four or five times. Then the vials were filled with 
wax without damaging the tissues. The vial filled with wax is kept open in 
warm condition to evaporate all TBA, leaving the specimen in pure molten 
wax. The specimen filled with pure molten wax for 2 or 3 times by decanting 
the old wax every time. 
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CASTING TO MOLD 
A boat made out of chart board, by folding the margin, is used to 
prepare a mold of wax containing specimens. The paraffin along with the leaf 
and petiole specimen was poured into the boat. With the help of heated 
needles, the specimen were arranged in parallel rows with enough space in 
between the specimens. The block was then immersed in chilled water and 
allowed to cool for few hours. 
 
SECTIONING 
The paraffin embedded specimens were sectioned with the help of 
microtome. The thickness of the sections was 10-12μm. Dewaxing of the 
sections was by customary procedure. The sections were stained with 
Toluidine blue as per the method published by O’Brien et al(1964). Since 
toluidine blue is a poly chromatic strain, the straining results were remarkably 
good and some cytochemical reactions were also obtained. The dye 
rendered pink colour to the cellulose walls, blue to the lignified cells, dark 
green to suberin, violet to the mucilage, blue to the protein bodies etc. 
Where ever necessary sections were also stained with safranin and fast-
green and potassium iodide (for starch). For studying the stomatal 
morphology, venation pattern and trichome distribution, paradermal sections 
(sections taken parallel to the surface of leaf as well as clearing of leaf with 
5% sodium hydroxide or epidermal peeling by partial maceration employing 
Jeffrey’s maceration fluid (Sass, 1940) were prepared. Glycerin mounted 
temporary preparations were made for macerated/cleared materials. 
Powdered materials of different parts were cleared with sodium hydroxide and 
mounted in glycerin medium after staining. Different cell components were 
studied and measured. 
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PHOTOMICROGRAPHS 
Microscopic descriptions of tissues are supplemented with micrographs 
wherever necessary. Photographs of different magnifications were taken. With 
Nikon labphot 2 Microscopic unit. For normal observations bright field was 
used. For the study of crystals, starch grains and lignified cells, polarized light 
were employed. Since these structures have birefringent property, under 
polarized light they appear bright against dark background. Magnifigations of 
the figures are indicated by the scalebars. (Johansen DA, 1940, Purvis MJ et 
al., 1966). 
 
4.2.3   MICROSCOPICAL STUDY OF LEAF USING SCANNING ELECTRON 
MICROSCOPE 
SCANNING ELECTRON MICROSCOPE (SEM) 
Movement of beam of focused electrons across an object forms a 3D 
image on a cathode - ray tube in a Scanning Electron Microscope and it reads 
both the electrons scattered by the object and the secondary electrons 
produced by it. The electromagnetic lenses are used in SEM and focusing is 
done by the current. On photographic plate of screen the image is projected 
which gives comprehensive, quasi 3-D representation of the objects gives the 
ultra-structure of plant cells. In addition, shows the unsuspected details and 
any undescribed characters. In other words the micrograph from SEM, shows 
the best possible structural details of the specimens. (Robards, 1970) 
 
USAGE 
SEM info was handled as conventional character (or) character 
complexes as “pure” information without being broken down (or) interpreted 
as individual character using computer processing. The SEM information can 
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be used somewhat at the superficial level just described to assist in solving 
taxonomic problem by confirming, changing (or) other grounds. It is also used 
often as diagnostic feature to avoid misleading by over simplified descriptions 
and one may find new kinds of microstructures not previously recognized and 
apparently simple structures may be extremely complex. Remarkably, poor 
conventional descriptions enabling taxonomic process of reducing a complex 
pattern to a few simple characters (Heywood VH, 1971). SEM plays a vital 
role when a specimen need to be satisfactorily defined in terms of characters. 
For most biological materials, maximum information is obtained by employing 
light and electron microscopy jointly and an attempt was made by applying 
SEM to the leaf of C.caudata, to pinpoint the positions of specific characters 
with in the cell, which can be easily seen in final image. 
 
SEM SAMPLE PREPARATION 
Sample for SEM analysis were mounted on the specimen stub using 
carbon adhesive sheet. Small sample were mounted with I sq. cm glass slide 
and kept in carbon adhesive sheet. Samples were coated with gold to a 
thickness of 100 AO using Hitachi vacuum evaporator. Coated sample were 
analyzed in a Hitachi Scanning electron Microscope 3000 H model. 
 
4.2.4 POWDER MICROSCOPY MACERATION TECHNIQUE 
Maceration is the process of separation of individual cells by selectively 
dissolving the pectic middle lamella between the cells. The middle lamella 
binds the cells with each other forming different tissues. The middle lamella is 
dissolved by employing a chemical that dissolves the lamella to free the cells 
to obtain their three dimensional view. 
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MACERATION FLUID 
Jaffrey’s maceration fluid is one that is commonly used for maceration 
(Johnsen DA, 1940). The fluid consists of equal volumes of 5% chromic acid 
and 5% nitric acid. The plant material is cut into small pieces and immersed in 
the maceration fluid. The fluid with the materials is kept at 55ºC for 3-5 hrs. 
Then the material is washed thoroughly with water and placed on a glass slide 
in a drop of Safranin (0.5%) for 15-20 min. The stain is drained carefully and 
mounted with a drop of dilute glycerine. The cells are spread well with a 
needle and the material is covered with cover slip. The slide so prepared is 
examined under the microscope to study different components of the 
macerate. 
 
 4.2.5  MICROSCOPIC SCHEDULES (Wallis TE. 1953, Wallis TE, 1965, 
Iyengar MA, 1994, Anonymous,2001) 
The vein islet number, vein terminal number, stomatal number and 
stomatal index were determined on fresh leaves using standard procedures. 
 
A.VEIN ISLET NUMBER AND VEIN TERMINATION NUMBER 
The term vein islet in used to denote the minute area of photosynthetic 
tissue encircled by the ultimate divisions of the conducting strands. The 
number of vein islets per sq.mm. Area is called vein islet number. 
Vein terminal number may be defined as the number of vein terminals 
present in one sq., mm. area of the photosynthetic tissue. 
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B. DETERMINATION  OF  VEIN  ISLET  NUMBER  AND  VEIN 
TERMINATION  NUMBER 
Small square portion from the lamina region of the leaf was cleared in 
chloral hydrate, stained and mounted on a slide. A camera Lucida is set up 
and by means of a stage micro meter the paper is divided into squares of 
1mm2 using a 16mm objective. The stage micro meter is then replaced by the 
cleared preparation and the veins are raced in four continuous squares, either 
in a square 2mm x 2mm (or) rectangle 1mm x 4 mm. 
When counting, it is convenient to number each vein-islet on the 
tracing. Each numbered area must be completely enclosed by veins, and 
those which are incomplete are excluded from the count if cut by the top and 
left-hand sides of the square (or) rectangle but included if cut by the other two 
sides. Ten readings for vein islet and vein termination number were recorded. 
C.STOMATAL INDEX 
It is the percentage, which the numbers of stomata from the total 
number of epidermal cells, each stoma being counted as one cell. 
Stomatal Index =    S / S+E x100 
Where,                       S = Number of stomata per unit area 
             E = Number of epidermal cells in the same unit area 
D.DETERMINATION OF STOMATAL INDEX 
The procedure adopted in the determinations of stomatal number was 
observed under high power (45 X).The epidermal cells and the stomata were 
counted. From these values the stomatal index was calculated using the 
above formula. 
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4.2.6   PHYSIOCHEMICAL PARAMETERS  (Anonymous, 1996, 1998, 2001) 
DETERMINATION OF ASH VALUES 
ASH VALUE 
The ash values were determined by using air dried powder of the leaf as 
per the official method. 
TOTAL ASH 
Two grams of the air dried leaf powder was accurately weighed in a 
silica crucible separately. The powder was scattered into a fine even layer on 
the bottom of the crucible and incinerated by gradually increasing the 
temperature not exceeding 450oc, until free from carbon. Then it was cooled 
and weighed for constant weight. The percentage of ash with reference to the 
air dried powder was calculated. 
WATER SOLUBLE ASH 
The ash obtained from the total ash procedure was boiled with 25ml of 
water for 5 minutes and the insoluble matter was collected on an ash less 
filter paper and washed with hot water. Then it was ignited for 15 minutes at a 
temperature not exceeding 450oc. The weight of the insoluble matter was 
subtracted from the weight of the total ash. The difference in weight 
represents the water soluble ash. The percentage of water soluble ash was 
calculated with reference to the air dried powder. 
ACID INSOLUBLE ASH 
The ash obtained from the total ash was boiled for five minutes with 
25ml of dilute hydrochloric acid. The insoluble matter was collected in a tarred 
sintered glass crucible. The residue was washed with hot water, dried and 
weighed. The percentage of acid insoluble ash with reference to the air dried 
drug was calculated. 
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DETERMINATION OF LOSS ON DRYING 
For the determination of loss on drying, the method described by Wallis 
was followed. One gram of dried powdered leaf was accurately weighed in a 
tarred Petri dish, previously dried under the conditions specified in IP’96. The 
powder was distributed as evenly as practicable, by gentle sidewise shaking. 
The dish was dried in an oven at 100 – 105°C for 1 hour. It was cooled in 
desiccators and again weighed. The loss on drying was calculated with 
reference to the amount of the dried powder taken. 
EXTRACTIVE VALUES 
Petroleum ether soluble extractive value 
Five gram of the coarsely powder was macerated separately with 
100ml of petroleum ether in a closed flask for 24 hrs. It was frequently shaken 
for the first 6 hours and allowed to stand for 18 hours. Thereafter it was 
filtered rapidly taking precaution against loss of petroleum ether. 25ml of the 
filtrate was evaporated to dryness in a tarred flat bottomed shallow dish, dried 
at 105oc and weighed. The percentage of the petroleum ether soluble 
extractive value was calculated with reference to the air dried powder. 
Ethanol soluble extractive value 
Five gram of the coarsely powder was macerated separately with 
100ml of ethanol in a closed flask for 24 hrs. It was frequently shaken for the 
first 6 hours and allowed to stand for 18 hours. Thereafter it was filtered 
rapidly taking precaution against loss of ethanol. 25ml of the filtrate was 
evaporated to dryness in a tarred flat bottomed shallow dish, dried at 105oC 
and weighed. The percentage of the ethanol soluble extractive value was 
calculated with reference to the air dried powder. 
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Water soluble extractive value 
Five gram of the coarsely powder was macerated separately with 100ml 
of chloroform water in a closed flask for 24 hrs. It was frequently shaken for 
the first 6 hours and allowed to stand for 18 hours. Thereafter it was filtered 
rapidly taking precaution against loss of chloroform water. 25ml of the filtrate 
was evaporated to dryness in a tarred flat bottomed shallow dish, dried at 
105oC and weighed. The percentage of the chloroform water soluble 
extractive value was calculated with reference to the air dried powder. 
4.3   PHYTOCHEMICAL STUDIES [Anonymous, 1998, Chaudhri RD, 
1999, Kokate CK, 2005, Agarwal, 2007, Horbone JB, 1973]. 
4.3.1 PRELIMINARY PHYTOCHEMICAL SCREENING TEST FOR 
ALKALOIDS: 
VARIOUS PROCEDURES TO LIBERATE ALKALOIDS 
 Powdered drug was mixed thoroughly with 1ml of 10% ammonia solution 
and then extracted for 10 minutes with 5 ml methanol, under reflux. The 
filtrate was then concentrated. 
 Powdered drug was mixed thoroughly with 1ml of 10% sodium carbonate 
solution and then extracted for 10 minutes with 5ml methanol, under reflux. 
The filtrate was then concentrated. 
 Powdered drug was ground in a mortar for about 1 minute with 2ml of 10% 
ammonia solution and then thoroughly mixed with 7 gram basic Aluminum 
oxide. The mixture was then loosely packed into a glass column and 10ml 
chloroform was added, eluted, dried and methanol was added. 
 Powdered drug was shaken for 15 minutes with 15ml of 0.1 N sulphuric 
acid and then filtered. The filter was washed with 0.1 N sulphuric acid 1 to a 
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volume of 20 ml filtrate:1ml concentrated ammonia was then added. The 
mixture was then shaken with two portions of 10ml diethylether.The ether 
was dried over anhydrous sodium sulphate filtered and evaporated to 
dryness and the resulting residue was dissolved in methanol. 
 Powdered drug was mixed with one gram of calcium hydroxide and 5ml of 
water, made into a smooth paste and set aside for 5 minutes. It was then 
evaporated to dryness in a porcelain dish on a water bath. 20ml of 90% 
alcohol was added, mixed well and then refluxed for half an hour on a water 
bath. It was then filtered and the alcohol was evaporated. To that dilute 
sulphuric acid was added. 
The above made extracts were tested with various alkaloid reagents as 
follows. 
1.  MAYER’S REAGENT 
2.  DRAGENDORFF’S REAGENT 
3.  HAGER’S REAGENT 
                 4.  WAGNER’S REAGENT  
TEST FOR CARBOHYDRATES  
MOLISCH’STEST 
The aqueous extract of the powdered material was treated with 
alcoholic solution of α - naphthol in the presence of sulphuric acid.  
FEHLING’S TEST 
The aqueous extract of the powdered material was treated with 
Fehling’s A and B solution and heated on a boiling water bath. 
BENEDICT’S TEST 
The aqueous extract of the powdered drug was treated with Benedict’s 
reagent and heated over a water bath. 
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TEST FOR GLYCOSIDES GENERAL TEST 
TEST A 
200 mg of the powdered drug was extracted with 5ml of dilute sulphuric 
acid by warming on a water bath, filtered and neutralized with 5% sodium 
hydroxide solution. Then 0.1ml of Fehling’s solution I and II were added, until 
it becomes alkaline and heated on a water bath for 2 minutes. 
TEST B 
200 mg of the powdered drug was extracted with 5ml of water instead of 
sulphuric acid. Boiled and equal amount of water was added instead of 
sodium hydroxide solution. Then 0.1ml of Fehling’s solution I and II were 
added, until it becomes alkaline and heated on a water bath for 2minutes. 
TEST  FOR  ANTHRAQUINONES  
BORNTRAGER’S TEST 
The powdered leaf was boiled with dilute sulphuric acid, filtered and to 
the filtrate benzene was added and shaken well. The inorganic layer was 
separated and ammonia solution was added slowly. 
 MODIFIED BORNTRAGER’S TEST 
About 0.1gram of the powdered leaf was boiled for two minutes with 
dilute hydrochloric acid and few drops of ferric chloride solution was added, 
filtered while hot and cooled. The filtrate was then extracted with benzene and 
the benzene layer was separated. Equal volume of dilute ammonia solution 
was added to the benzene extract and shaken well. 
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TEST FOR CYANOGENETIC GLYCOSIDES 
Small quantity of the powdered leaf was placed in a stoppered conical 
flask with just sufficient water to cover it. A sodium picrate paper strip was 
inserted through the stopper so that it was suspended in the flask and it was 
set aside for 2 hours in a warm place. 
TEST FOR CARDIAC GLYCOSIDES  
KELLER KILLIANI’S TEST 
About 1gram of the powdered leaf was boiled with 10ml of 70% alcohol 
for two minutes, cooled and filtered. To the filtrate 10ml of water and 5 drops 
of solution of lead sub acetate were added and filtered. The filtrate was then 
extracted with chloroform and the chloroform layer was separated and 
evaporated to dryness. The residue was dissolved in 3ml of glacial acetic acid 
containing a trace of ferric chloride. To this 3ml of concentrated sulphuric acid 
was added along the sides of the test tube carefully. 
RAYMOND TEST 
To the alcoholic extract of the leaf, hot methanolic alkali was added 
LEGAL’S TEST 
To the alcoholic extract of the powdered drug, pyridine and alkaline 
sodium nitro pruside solution were added. 
COUMARIN GLYCOSIDES 
A small amount of powdered leaf was placed in test tube and covered 
with a filter paper moistened with dilute sodium hydroxide solution. The 
covered test tube was placed on water bath for several minutes. Then the 
paper was removed and exposed to UV light. 
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TEST FOR PHYTOSTEROLS 
The powdered leaf was first extracted with petroleum ether and 
evaporated. The residue obtained was dissolved in chloroform and tested for 
sterols. 
SALKOWSKI TEST 
Few drops of concentrated sulphuric acid were added to the above 
solution, shaken well and set aside. 
 
LIBERMANN – BURCHARD’S TEST 
To the chloroform solution few drops of acetic anhydride was added 
and mixed well. 1ml of concentrated sulphuric acid was added through the 
sides of the test tube and set aside for a while. 
 
TEST FOR SAPONINS 
About 0.5gram of the powdered leaf was boiled gently for 2 minute with 
20 ml of water and filtered while hot and allowed to cool. 5ml of the filtrate was 
then diluted with water and shaken vigorously. 
DETERMINATION OF FOAMING INDEX 
One gram of the coarsely powdered leaf was weighed and transferred 
to 500 ml conical flask containing 100 ml of boiling water. The flask was 
maintained at moderate boiling, at 80-90oC for about 30 minutes. Then it was 
cooled and filtered into a volumetric flask and sufficient water was added 
through the filter to make up the volume to 100 ml (V1). Ten Stoppard test 
tubes were cleaned (height 16 cm, diameter 1.6 cm) and marked from 1 to 
10. Measured and transferred the successive portions of 1, 2, 3ml up to 10ml 
and adjusted the volume of the liquid in each tube with water to 10ml. Then 
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the tubes were Stoppard and shaken lengthwise for 15 seconds, uniformly 
and allowed to stand for 15 minutes and measured the length of the foam in 
every tube. 
TEST FOR TANNINS 
To the aqueous extract of the powdered leaf, few drops of ferric 
chloride solution were added. 
GOLD BEATER’S SKIN TEST 
2% hydrochloric acid was added to a small piece of gold beater skin 
and rinsed with distilled water and placed in the solution to be tested for five 
minutes. Then washed with distilled water and transferred to a 1% ferrous 
sulphate solution. 
TEST FOR PROTEINS AND FREE AMINOACIDS  
MILLON’S TEST 
The acidulous alcoholic extract of the powdered leaf was heated with 
Millon’s reagent. 
BIURET TEST 
To the alcoholic extract of the powdered leaf 1ml of dilute sodium 
hydroxide was added. Followed by this one drop of very dilute copper 
sulphate solution was added. 
NINHYDRIN TEST 
To the extract of the powdered drug, Ninhydrin solution was added, and 
boiled. 
TEST FOR MUCILAGE 
To the aqueous extract of the powdered leaf, Ruthenium red solution 
was added. 
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TEST FOR FLAVONOIDS SHINODA TEST: 
A little amount of the powdered leaf was heated with alcohol and 
filtered. To the alcoholic solution a few magnesium turnings and few drops of 
concentrated hydrochloric acid were added, and boiled for 5 minutes. 
ALKALINE REAGENT TEST 
To the alcoholic extract of the powdered leaf, few drop of sodium 
hydroxide  solution was added. 
ZINC HYDROCHLORIDE TEST 
To the alcoholic extract, mixture of zinc dust and concentrated 
Hydrochloric acid was added. 
TEST FOR TERPENOIDS 
The powdered leaf was shaken with petroleum ether and filtered. The 
filtrate was evaporated and the residue was dissolved in small amount of 
chloroform. To the chloroform solution tin and Thionyl chloride were added. 
TEST FOR VOLATILE OIL 
About 100gram of fresh leaves, were taken in a volatile oil Clevenger 
apparatus and subjected to hydro distillation for four hours. 
TEST FOR FIXED OIL 
A small amount of the powdered leaf was pressed in between in the 
filter paper and the paper was heated in an oven at 105oC for 10 minutes. 
4.3.2. FLUORESCENCE ANALYSIS 
Powdered leaf material Of Commiphora caudata was subjected to 
analysis under UV light after treatment with various chemical and organic 
reagents like.  
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Ethanol, Ethyl acetate, Chloroform, Water, 50% sulphuric acid, 10% 
sodium hydroxide, 50% nitric acid and dried leaf powder. (Horbone JB, 1973). 
 4.3.3  ESTIMATION OF FLAVONOID CONTENT 
[Chang C C et al., 2002, Mabry T Jet al., 1970 and Siddiquie M A et al., 2010]. 
The flavonoid content of plant extract was estimated by aluminium 
chloride method. In this method, aluminium chloride complexes  with 
flavonoids of C3-C5 hydroxyl group and to produce intense colour in acidic 
medium. The intensity of the colour is proportional to the amount of flavonoids 
and can be estimated as quercetin equivalent at wavelength of 415nm. 
MATERIALS REQUIRED 
Ethanolic extract of leaves of C.caudata 
10%w/v Aluminium chloride 
1M Potassium acetate 
95%v/v ethanol 
PROCEDURE 
0.5ml of the extract (1mg/ml) was transferred to a test tube. To this 
solution, 0.1ml of aluminium chloride, 0.1ml of potassium acetate, 1.5ml 
ethanol were added and made up to 5ml with distilled water. The mixture was 
allowed to stand for 30 min with intermittent shaking. The absorbance was 
measured at 415nm.  
The calibration curve was generated using quercetin as a standard at 
different concentrations (5-50µg/ml). The reaction mixture without aluminium 
chloride was used as a blank. The flavonoids content was expressed as mg of 
quercetin equivalent per gram of extract. 
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4.3.4. ESTIMATION OF TOTAL PHENOLIC CONTENT (Singleto VL et al., 
1979, Gouthamchandra K et al.,2010) 
PRINCIPLE 
The total phenolic content of the extract was determined by Folin&Cio-
calteu’s phenol reagent. This reagent consists of phosphotungstate and 
phosphomolybdate mixture which is reduced to mixture of blue molybdenum 
and tungsten oxides while phenolic content of the extract was oxidized. The 
intensity of colour is proportional to the amount of phenolic content of the 
extract and which was measured at 765nm. The total phenolic content in the 
extract was expressed as milligrams of gallic acid equivalent (GAE) per gm of 
extract. 
MATERIALS 
 Ethanolic extract of leaves of C.caudata 
 10%w/v sodium carbonate solution 
 Gallic acid 
 Folin & Cio-calcateu’s phenol reagent 
PROCEDURE 
0.5ml and 1ml of extract was transferred into separate test tube. To this 
solution, FCR 0.5ml and 1ml of sodium carbonate were added and final 
volume made up to 10ml with distilled water. The mixture was allowed to 
stand for 1hr with intermittent shaking. The absorbance was measured at 
765nm. A calibration curve was generated using Gallic acid as a standard at 
different concentrations (2, 4, 6, 8, 10µg/ml). The reaction mixture without 
sample was used as a blank. The total phenolic content was expressed as 
milligrams of Gallic acid equivalent (GAE) per g of extract. 
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4.3.5. DETERMINATION OF TRACE ELEMENTS IN THE LEAF OF C.caudata   
          BY ENERGY DISPERSIVE X-RAY SPECTROMETER (EDS) 
The SEM allows the observation of materials in macro and submicron 
ranges. SEM is capable of generating 3-D images for analysis of topographic 
features. When SEM is used along with EDS the analyst can perform an 
elemental analysis on specimens of microscopic sections or contaminants 
that may be present. 
EDS ANALYTICAL CAPABILITIES 
Backscattered electron images in the SEM display compositional 
contrast that results from different atomic number elements and their 
distribution. EDS is used to find particular elements are and their Atomic %. 
The Y-axis shows the counts (number of X-rays received and processed by 
the detector) and the X-axis shows the energy level of those counts [Bob 
Hofner]. 
By Viewing 3-D images of specimens solves some of the problem in an 
analysis  and it is also necessary to detect different elements associated with 
the specimen. This is accomplished by using the “built-in” spectrometer called 
an Energy Dispersive X-ray Spectrometer. 
EDS SYSTEM COMPRISES OF 3 BASIC COMPONENTS  
 An X-ray Detector - detects and converts X-ray into electronic signals. 
 A Pulse Processor - measures the electronic signals to find out energy of 
each X- ray detected; and 
 A Multiple Channel Analyzer - interprets and displays analytical data. 
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EDS is an analytical technique in which the specimen emits X-rays due 
to the bombardment of electron beam on it which is used to identify the 
elemental composition of the specimen due to the ejection of electrons from 
the atoms on the specimen surface. To explain further, when the sample is 
bombarded by the electron beam of the SEM, electrons are ejected from the 
atoms on the specimen’s surface. A resulting electron vacancy is filled by an 
electron from a higher shell, and an X-ray is emitted to balance the energy 
difference between the two electrons. The EDS X-ray detector measures the 
number of emitted X-rays emitted versus their energy. The energy of the X-
ray is characteristic of the element from which the X-ray was emitted. A 
spectrum of the energy versus relative counts of the detected x-rays is 
obtained and evaluated for the determinations of the elements. 
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4.3.6. PREPARATION  OF  ETHANOLIC  EXTRACT  FROM  THE  LEAVES  
OF   C.caudata (EECCL) 
Weighed quantity of fresh leaves was extracted with 90% v/v ethanol 
by cold maceration for three days and the solvent was evaporated under 
reduced pressure using Buchi Rotovapor apparatus. Residue was collected 
and stored in refrigerator until use. 
4.3.7  IDENTIFICATION OF COMPOUNDS PRESENT IN THE ETHANOLIC 
EXTRACT OF LEAVES BY HPTLC ANALYSIS 
High performance thin layer chromatography (HPTLC) is a modern 
adaptation of TLC with improved versatility, separation efficiency and 
detection limits. HPTLC is a useful tool for identification of plant extract 
because each plant species produces a distinct chromatogram, with unique 
marker compounds used for the plant identification. It is used as a quality 
control tool since comparison of chromatograms of different lots can 
demonstrate the similarities and differences between the test samples and 
their standard chemical markers. HPLTC it is a reliable method for 
quantification of nanogram level even when present in complex formation. 
HPTLC fingerprint analysis is used for rapid identity check, for monitoring 
purity of drugs, for detection of adulterants, for determining whether a material 
is derived from adefined botanical species and also to know whether the 
constituents are clearly characterized (Wagner, H et al., 1996).   
          Instrument used            :        CAMAG TLC Scanner 3  
          Software                        :     win CATS Planar Chromatography    
                                                                  Manager  
          Sample application       :      Linomat 5  
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          Detection                      :      at 254nm in TLC Scanner 3  
          Stationary phase           :     HPTLC plates silica gel 60 F 254  
          Sample preparation      :    100mg per ml of sample was  
                                                                   prepared   in  ethanol solvent.  
          Mobile phase               :    Toluene : Acetone (9:1) 
          Sample solution              :    5µL  
          Standard solution           :    5µL  
          Drying device                :     Oven  
          Temperature                 :     60°C  
          Volume                        :   10.0ml  
          Scanning speed                    :        20mm/s 
         Time                              :   5minutes    
          Wavelength                   :    254 nm 
          Lamp                              :     D2&W  
          Measurement type          :    Remission  
          Measurement mode      :    Absorption 
 
4.4 PHARMACOLOGICALSTUDIES 
4.4.1. PRELIMINARY TOXICOLOGICAL STUDIES OF EECCL ON THE 
EMBRYO AND LARVAE OF ZEBRAFISH 
Toxicology through intensive studies has traditionally focused on the 
effects of chemicals on living organisms which was done by one chemical at a 
time. Such approaches show the mode of action of many chemicals and 
provide a detailed mechanistic understanding of the molecular targets of 
toxicity for some as the cost of this approach is high. Toxicology studies rely 
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on the utility of vertebrate animals which is an expensive undertaking in both 
time and cost with debatable predictive power in case of safety aspects for 
human. (Bucher, JR2002). 
Role of zebra fish in high throughput screening: 
In the last two decades safety pharmacology has become a most 
important part of the non- clinical safety assessment in finding new chemical 
entities (Bass, A et al., 2004). 
The relative novelty of this discipline has granted it the flexibility to 
incorporate new experimental tools (Claude, JR and Claude, N 2004). 
In addition to requiring small amount of compounds, the time and cost 
effectiveness of invitro assays have led to their use by the pharmaceutical 
industry for high or medium throughput safety screens (Suter, W.2006). 
One of the limitations encountered with in vitro studies is that they are 
not fully representative of in vivo models. Therefore, safety pharmacology 
needs an in vivo model with the capacity for higher throughput screening. 
Thezebra fish model system is done from medium to high throughput because 
of many advantages, as they are small in size, cheap to maintain and 
fecundity as a single spawning produces 100 – 200 eggs. Larvae, which are 
only 1-4 mm long, can live for seven days in a single well of a standard 96 or 
386 – well microtitre plate by the support of nutrients stored in the yolk sac. 
Administration of drugs in zebra fish: 
Larvae of zf can absorb small molecules diluted in the surrounding 
water through their gills and skin. Drugs can be given orally after this stage 
because zebra fish begin to swallow at 72(hpf).Drugs can also be delivered by 
oral intubation in case of adult zf. Compared to testing in other animals 
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models, statistically significant numbers of zebra fish can be used for each 
assay and small amounts (mg) of drugs are required.in addition the 
transparency of zebra fish larvae for several days of post fertilization (dpf) 
enables in vivo observation of live or whole fixed specimens, including the 
visualization of vital dyes, fluorescent tracers, antibodies and riboprobes. By 
120 hpf, zebra fish develop discrete organs and tissues, including brain, heart, 
liver, pancreas, intestines, bone, muscles, nerve systems and sensory 
organs. These organs and tissues have been shown to be similar to their 
mammalian counter parts at the anatomical, physiological and molecular 
levels. Although conventional in vitro assays using cultured cells can be used 
to evaluate potential drug toxicity effects, results are frequently not predictive 
.Results in vivo will involve drug absorption, distribution, metabolism excretion 
(ADME). To streamline the drug development timeline prioritize drug 
candidates for animal testing and reduce unnecessary costs for mammalian 
studies, drug screening assays using zf are becoming increasing popular .(Mc 
Grath P and Chun-Qi Li 2008). 
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MORPHOLOGY OF ZEBRA FISH LARVAE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anatomy and cardiovascular development in Zebra fish: 
As in all vertebrates, the heart is the first organ to function in zf. It 
develops rapidly and is fully formed by 2 dpf, compared with 12 dpf in the 
mouse and 35 dpf in the human embryo at 3 weeks gestation. Zf hearts, like 
those of humans, start out as linear heart tube and start to loop 24 – 36 hour 
post fertilization (hpf). 
Zf cardiac contraction begins at 22 hpf initially as a peristaltic wave 
which then develops into co – ordinate contractions of the atrium and ventricle 
by 36 hpf. Blood is first sent from the heart to gills where it is oxygenated. It 
then passes to the head before moving posteriorly to the rest of the body. 
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Despite the lack of a pulmonary circulationand its two chambered heart, there 
is significant conservation between mammalian and zf cardiovascular at 
morphologic, physiologic and genetic level, making it a useful model for 
studying cardiac development (Dooley, K and Zon, Li 2000). 
A. WHOLE EMBRYO CULTURE TOXICITY STUDY 
Materials 
Fertile eggs, E3embryo medium (standard medium), 
dimethylsulphoxide (DMSO), glass petridishes, research  microscope 
(laboratory microscope with microphotography), incubator, micropipette, 
EECCL of C.caudata and standard podophyllotoxin. 
Collection of eggs 
Eggs were collected from natural spawning and reared in embryo 
medium at pH 7.2, and kept in an incubator at 28±0.50Cfor our assay. The 
developmental assay stage of the embryos was determined using 
microscope. (Hisaoka, KKand Battle, HI (1958). At around 2- 4h post 
fertilization, only the fertilized eggs (blastula stage) were selected. The 
fertilized eggs were collected and rinsed several times with tap water. 
EXPERIMENTAL DESIGN: 
The eggs were transferred to each of the glass petri dishes (3 per 
dish) containing different concentration of EECCL (0.5, 0.75, 1 and 2µg/ml) 
dissolved in 1% DMSO at 28OC as well as DMSO control. Embryo medium 
served as the over-all control. Standard podophyllotoxin of concentration 
10µg/ml was taken as positive control .occasional stirring was done to ensure 
even distribution of the chemical. The maximal acceptable toxicant 
concentration (MATC) was calculated accordingly by scoring the 
malformations. (Dave, G et al., 1987) 
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The development of blastula eggs was monitored at specified time 
points (12, 36, 60, & 80 hrs.) under microscope. Endpoints were used for 
assessing the effect of drug during the major organ is visible included edema, 
eye, malformations, bent tail, undulated notochord, twisted notochord and 
death. Malformations were also noted and described among the juveniles 
from the control 1% DMSO treated and standard podophyllotoxin. 
B. LARVAL TOXICITY STUDY 
Materials 
Zf larvae of 5 dpf ,E3 embryo medium ,1% DMSO, glass petri dishes 
,research microscope (labscope microscope with microphotography) , 
incubator, micropipette,  volatile oil of C.caudata in various concentration and 
standard podophyllotoxin. 
Experimental design 
Healthy 5 dpf larvae was selected and used for larval toxicity study. 
About 5 larvae were released in the embryonic medium (10ml) taken in a 
petridish, in triplicate. Various concentration of EECCL (0.5, 0.75, 1 and 
2µg/ml) dissolved in 1% DMSO and tested. Podophyllotoxin (10µg/ml) was 
used as standard toxin. 
4.4.2 EFFECT OF EECCL IN DOX INDUCED CARDIO TOXICITY ON  
             ZEBRAFISH EMBRYOS 
 The embryos, 1 dpf were arrayed into 96 well plates (n=3) containing 
200µl of E3 medium buffered with Hepes (pH7.2). 
 The embryos were treated with DMSO (vehicle control), 100 µM 
Doxorubicin, Doxorubicin + EECCL (0.5 ng, 1 ng 1.5 ng), Doxorubicin + 
Metaprolol (standard drug) and untreated. 
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 Microscopic examination of all treated and untreated zf showed various 
phenotypic changes, the end points like pericardial edema, heart atrium, 
ventricle and blood circulation within the tail blood vessels were 
observed. 
 Heart rate and Contractility recorded using high speed camera and a 
custom analysis algorithm, and the fractional shortening of the zebra fish 
hearts were calculated. 
 Quantification of Fractional shortening(FS) as follows, 
   VIDd –VIDs /VIDd *100 
VIDd – Diastolic ventricular internal dimension 
VIDs – Systolic ventricular internal dimension (Liu et al., 2015). 
 Statistical significance was analyzed using one way ANOVA. 
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CHAPTER V 
  RESULTS 
 
5.1 PHARMACOGNOSY(PLATE 1) 
5.1.1 MORPHOLOGICAL STUDIES OF C.caudata leaves 
Commiphora caudata can be found in Southern India and Sri Lanka, 
usually growing in the full sun on hilly granite rock outcrops in dry zone 
areas. It is a small to medium-sized deciduous tree which is said to be able 
to reach height of 10-20m, but usually is less high. The tree has a smooth, 
succulent green bark, which partly flakes off with age, giving rise to a 
characteristic patchwork of green and brown patches. Its sap has a strong 
resinous scent. The tree has medicinal properties. The fruit is a globose 
fleshy drupe with 2 to 6 valves and 1 seed that is black and has 4 wings. 
Remnants of branches can form a kind of thorns on the trunk.  
Macroscopic characters: 
LEAVES: (PLATE 2,3)      
Leaves were compound 
  Shape                     :        Ovate, oblong 
  Arrangement        :        Alternative, leaflets 3 to 7 foliolate,     broadly   
                                        Ovate, lanceolate, leaves imparipinnate, 
  Texture                 :       Glabrous, glossy above, subglaucous below 
                                       and caudate. 
  Size                       :      4.5 to 6.5 cm long and 2.2 to 3.5 cm wide. 
    Pedicle                  :      length - 3.5 to 6.2 cm 
    Color                     :      Upper surface dark green, lower surface                          
                                          light green in colour  
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    Margin                   :      Entire  
    Base                      :      Slightly asymmetric 
    Apex                      :       Acuminate 
    Petiole                   :       Slender 1.5-2 cm long. 
    Venation                :       Reticulate pinnate 
  Leaves falling          :       During the hot season. 
FLOWERS (PLATE 4) 
Colour            :  The flowers have a greenish to cream-yellow          
    pedestal with Cream to reddish petals. 
 Arrangement        :            Flowers are polygamous, the flowers are 4- 
merous and  grouped in few- flowered and  
axillary paniculate dichasial cymes with  solitary 
seeds                   
  Odour          : Fragrant 
The calyx  :  Cup-shaped with 4 lobes.  
Size of calyx tube   :          2 mm long and 3 mm in diameter  
Colour    :  yellow - pinkish and glabrous. 
 Shape of lobes :   Triangular and 1.5 mm long and wide 
The corolla    :  4 yellow-pinkish-colored and glabrous petals. 
The petals are oblong and recurved at the end 5 
mm long and 2 mm wide. 
The androecium :  composed of 8 stamens. Free. The filaments are 1.5-2            
mm long and connate and the anthers are oblong       
The pistil               :   composed of a 1 mm long style and a 2-
lobed stigma. Ovary bilocular  with two ovules per 
locule, axile placentation. 
Flowering season :   From March to May. 
CHAPTER V                                                                             RESULTS 
DEPARTMENT OF PHARMACOGNOSY, COP, MMC, MADURAI Page 77 
 
 FRUITS(PLATE 5) 
 Shape   :  Globose, fleshy drupe 
           Size    :   1.5 cm 
        Fruiting season        :  From August to January 
BARK(PLATE 6) 
       Colour              :   greyish,new bark-bright green 
      Texture              :   smooth, papery, branchlets glabrous 
SEEDS (PLATE - 7) 
  Colour           :     Black  
      Arrangement        :     Solitary with 4 radiating wings 
Seeding season       :     From August to January. 
WOOD: 
 The heartwood is grey with darker streaks 
  The sapwood is white 
5.1.2 MICROSCOPY OF THE LEAF   
5.1.3 Microscopic characters: 
T.S.of midrib(PLATE 8) 
Transverse section of midrib of leaflet shows prominent midrib a 
small projecting hump on the adaxial side and mucous cell is found at the 
centre. 
Palisade tissue is not continuous over the midrib region. The ground  
tissue is made up of closely arranged round to oval parenchyma cells.  
T.S.of Lamina(PLATE 9) 
Leaf is dorsiventral in nature. Adaxial epidermal cells are angular, 
straight and thick walled covered by a thick cuticle. Mesophyll is differentiated 
in to palisade tissue occur beneath the epidermis as single layered, columnar 
and closely arranged cells and lobed aerenchymatous spongy parenchyma 
PLATE 1 & 1A 
 HABIT AND HABITAT OF Commiphora caudata 
       PLATE  2 
 BRANCH SHOWING   LEAF ARRANGEMENT OF  C.caudata 
    PLATE 3 
    DORSAL  VIEW OF  C.caudata 
        PLATE 3A 
  VENTRAL VIEW OF C.caudata 
  PLATE  4 
       FLOWER BUDS OF C.caudata 
         PLATE  5 
      FRUITS OF C.caudata 
  PLATE 6 
BARK OF C.caudata 
PLATE  7 
 
DIAGRAMMATIC REPRESENTATION OF C.caudata 
 
 
 
 
 
 
 
 
 
 
 
 PLATE 8 
      T.S OF LEAF THROUGH MIDRIB [MICROTOME SECTION] 
   PLATE 8 A 
 T S OF  MIDRIB - ENLARGED 
PLATE 8 B 
     T S OF MIDRIB [HAND SECTION] 
        PLATE 9     
  T.S OF LAMINA [MICROTOME SECTION] 
PLATE 9 A 
T S OF LAMINA [HAND SECTION] 
PLATE 10  
UPPER  EPIDERMIS SURFACE VIEW OF STOMATA OF C.CAUDATA 
PLATE 10 A 
       LOWER  EPIDERMIS SURFACE VIEW OF STOMATA OF C.CAUDATA 
PLATE 11 A 
       T.S OF PETIOLE [MICROTOME SECTION] 
PLATE 11 B 
     T.S OF PETIOLE [ HAND SECTION] 
Xylem 
Phloem 
Secretory 
canal 
      PLATE 12 
  VENATION OF C.caudata 
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cells. 
A noteworthy feature is the presence of secretory cavities lined with 
epithelium cells occur below the epidermis on either side of the leaf. 
Vascular bundle: One larger median bundle and one smaller adaxial 
accessory bundle. Secretory cavities occur in the phloem region.  
Stomata are actinocytic. (PLATE 10) 
T.S. of petiole(PLATE 11) 
Transverse section of petiole is nearly circular in outline. Epidermis is 
made up of single layer of rectangular thick walled cells covered by a thick 
cuticle. The inner region is composed of ring of vascular bundle to 12 layers 
of parenchyma cells. Secretory canals situated below the epidermis in the 
cortical region.  
5.1.3 SCANNING ELECTRON MICROSCOPY (SEM) (PLATE 13): 
The Scanning Electron Microscopy with its relatively highly resolution 
and great depth of focus, provide topographical and morphological 
information. SEM studies showed the unicellular trichome and its occurrence 
and arrangement. Actinocytic stomata was predominantly observed. 
5.1.4 POWDER MICROSCOPY(PLATE 14) 
Green in colour, odour aromatic, taste mucilaginous. Microscopically 
showed fibres, actinocytic stomata, xylem vessels, phloem with companion 
cells, secretary cells, parenchyma cells. 
 5.1.5   MICROSCOPIC SCHEDULES 
As per the methods described in materials and methods, 
microscopic schedules were carried out and the results tabulated from the 
Tables 1- 3 
 
 
PLATE 13 
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Table – 1 
VEIN ISLET AND VEIN TERMINATION NUMBER OF C.caudata LEAVES 
OBSERVATION 
NUMBER 
VEIN ISLET 
NUMBER 
VEIN 
TERMINATION 
NUMBER 
1 5 3 
2 4 2 
3 6 1 
4 6 1 
5 5 1 
6 4 2 
7 5 1 
8 6 2 
9 4 1 
10 5 4 
Minimum 4 1 
Average 5 1.8 
Maximum 6 4 
 
Table – 2 
STOMATAL NUMBER OF C.caudata LEAVES 
 
OBSERVATION 
NUMBER 
LOWER 
EPIDERMIS 
UPPER 
EPIDERMIS 
1 11 6 
2 13 9 
3 12 7 
4 12 7 
5 13 7 
6 11 8 
7 11 8 
8 12 7 
9 13 9 
10 11 6 
Minimum 11 6 
Average 12 7.5 
Maximum 13 9 
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Table – 3 
STOMATAL INDEX OF C.caudata LEAVES 
OBSERVATION 
NUMBER 
UPPER 
EPIDERMIS 
LOWER 
EPIDERMIS 
1 18 10 
2 14 12 
3 17 12 
4 13 11 
5 15 10 
6 15 10 
7 14 12 
8 15 11 
9 22 16 
10 16 10 
Minimum 13 10 
Average 15.90 11.40 
Maximum 22 16 
 
5.1.1 PHYSIO CHEMICALPARAMETERS 
As per the methods described in materials and methods, 
physicochemical parameters were carried and the results were as 
follows. 
Table – 4 
ASH VALUES OF THE OF C.caudata LEAVES 
 
OBSERVATION 
NUMBER 
TOTAL 
ASH (%) 
ACID 
INSOLUBLE 
ASH (%) 
WATER 
SOLUBLE 
ASH (%) 
1 10.5 2.5 
2 8.8 2.6 
3 9.5 2.5 
4 9.4 2.6 
5 9.3 2.9 
6 9.1 7.1 
7 10.3 7.5 
8 10.1 7.3 
9 10.5 7.6 
10 9.6 7.2 
Minimum 8.8 2.5 7.1 
Average 9.71 2.62 7.24 
Maximum 10.5 2.9 7.8 
 
     
                                 
 
FIGURE 1 
 
DIAGRAMMATIC REPRESENTATION T.S. OF MIDRIB 
 
 
 
 
 
 
 
 
 
  
 
 
 
FIGURE 2 
 
DIAGRAMMATIC REPRESENTATION T.S. OF LAMINA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PLATES 14 
 
POWDER MICROSCOPY OF C.caudata 
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Table – 5 
LOSS ON DRYING (LOD) of C.caudata LEAVES 
OBSERVATION NUMBER LOD %w/w 
1 5.7 
2 5.5 
3 5.5 
4 4.9 
5 5.2 
Minimum 4.9 
Average 5.36 
Maximum 5.7 
 
 
Table – 6 
EXTRACTIVE VALUES FOR C.caudata LEAVES 
SOLVENTS EXTRACTIVE VALUE (%) 
Petroleum ether 10.15 
Ethanol 8.2 
Water 10.5 
 
5.2 PHYTOCHEMICAL STUDIES 
5.2.1 PRELIMINARY PHYTOCHEMICAL SCREENING QUALITATIVE 
PHYTOCHEMICALTESTS: 
Preliminary phytochemical screening of the powdered mature leaves 
was performed and the results are as follows (Table 7) 
TEST FOR ALKALOIDS 
Mayer’s test :  No appearance of cream precipitate shows 
the absence of alkaloids 
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Dragendorff’s test : No appearance of reddish brown precipitate 
shows the absence of alkaloids 
Hager’s test : No appearance of yellow precipitate shows 
the absence of alkaloids 
TEST FOR CARBOHYDRATES 
Molisch’s test : Appearance of purple colour shows the 
presence of carbohydrates. 
Fehling’s test : Formation of reddish brown precipitate shows 
the Presence of free reducing sugars. 
Benedict’s test : Formation of reddish brown precipitate shows 
the Presence of free reducing sugars. 
TEST FOR GLYCOSIDES 
General test 
Test A    : No red colour precipitate shows the    
                                                   absence of glycosides 
Test B    :  No appearance of red colour shows  
the presence of glycosides 
Keller  Killani’s test  :       No reddish brown colour ring at the junction 
shows the absence of cardiac glycosides 
Borntrager’s test  :       No pink colour shows the absence of      
                                                    anthraquinone  glycosides 
Modified Borntrager’s test  :       No pink colour in ammoniacal layer shows the       
   absence   of  anthraquinone  glycosides. 
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TEST FOR PHYTOSTEROL 
Salkowski’s test           : Appearance of red colour in lower layer 
 shows the presence of sterol. 
Liebermann – 
Burchard’s 
test 
: Brown ring at the junction of two layers and green 
colour in the upper layer shows the presence of 
sterols 
 
TEST FOR SAPONINS  :     Frothing occurs indicates the presence of 
             Saponins 
TEST FOR TANNINS 
Ferric chloride test  : Appearance of bluish black colour shows  
the Presence of tannins 
Gold beater skin test :  Appearance of brown colour shows the  
                                                       presence  of tannins 
 
TEST FOR PROTEINS AND FREE AMINOACIDS 
Millon’s test : Appearance of red colour on heating shows the 
presence of proteins 
Biuret test : Appearance of violet colour shows the presence 
of proteins 
Ninhydrin test : Formation of violet colour shows the presence of 
amino acids. 
 
TEST FOR TERPENOIDS 
Appearance of pink colour shows the presence of terpenoids 
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TEST FOR FLAVONOIDS 
Shinoda test : Purple colour shows the presence of 
flavonoids 
Alkaline reagent test 
 
    :     
 
Yellow - orange colour shows the presence 
of flavonoids . 
Acid test : Yellow – orange colour shows the presence 
of flavonoids 
Zinc hydrochloride 
test 
: Red colour shows the presence of 
flavonoids.  
 
TEST FOR VOLATILE OIL 
Volatile oil was not obtained shows the absence of volatile oil 
 
TEST FOR FIXED OIL 
No translucent greasy spot shows the absence of fixed oil 
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Table – 7 
PRELIMINARY PHYTOCHEMICAL SCREENING OFLEAVES OF 
C.caudata 
S.NO TEST OBSERVATION 
I. ALKALOIDS 
Mayer’s reagent - 
Dragandorff’s reagent - 
Hager’s reagent - 
II. CARBOHYDRATES 
Molisch’s test + 
Fehling’s test + 
Benedict’s test + 
III. GLYCOSIDES 
Anthroquinone glycosides - 
Borntrager’s test - 
Modified Borntrager’s test - 
Cardiac glycosides 
Keller Kiliani test - 
Raymond test - 
Legal test - 
IV. STEROLS 
Salkowski test + 
LibermanBurchard’s test + 
V. SAPONINS + 
VI. TANNINS 
Ferric chloride + 
Gold Beater’s skin test + 
VII. PROTEINS AND FREE AMINO ACIDS 
Millon’s test + 
Biuret test + 
Ninhydrin test + 
VIII. MUCILAGE + 
IX. TERPENOIDS + 
X. FLAVONOIDS 
Shinoda test + 
Alkali test + 
Acid test + 
Zn/Hcl test + 
XI. VOLATILE OIL _ 
XII. FIXED OIL _ 
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5.2.2 FLUORESCENCE ANALYSIS 
The fluorescence analysis of the leaf powder of C.caudata was 
studied.    
The results were as follows (Table -8) 
Table -8  
           FLUORESCENCE ANALYSIS 
Reagent Observation 
Powder as such Dark Green 
Powder + 50% Hydrochloric acid Yellowish Green 
Powder + 50% Nitric acid Light brown 
Powder + Petroleum ether Light orange 
Powder + 50% Sulphuric acid Dark brown 
Powder + 1N NaOH in water Dark green 
Powder + 1N NaOH in methanol Dark Green 
Powder +5% Ferric chloride 
solution Greenish brown 
Powder + Picric acid Fluorescence green 
Powder + Chloroform Green 
 
5.2.3  ESTIMATION OF FLAVONOID CONTENT 
Flavonoid content of extract in terms of quercetin by aluminium 
chloride was found to be 7.8 mg/g. 
 
5.2.4  ESTIMATION OF TOTAL PHENOLIC CONTENT 
    Total phenolic content of extract in terms of Gallic acid was found to 
be 18.8 mg/g. 
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5.2.5 IDENTIFICATION OF COMPOUND PRESENT IN THE EECCL  BY 
HPTLC ANALYSIS 
Sample Information: Sample ID: Ethanol extract of C. caudate leaf 
About 5μl of standard quinine, 5μl of EECCL  was applied as a band using 
CAMEG  Linomat sample applicator on aluminium sheets pre-coated with 
silica gel 60 GF 254 HPTLC plates used as a stationary phase. The plates 
were developed in the mobile phase Toluene: acetone (9:1) to a distance of 
80 mm in CAMAG trough glass chamber. The tracks were scanned using 
WIN CATS 1.43 software at 254nm. The fingerprint profiles were recorded 
and presented. The plot showed 12 spots after development with the mobile 
phase. 
HPTLC profile for the following compounds revealed that, 
HPTLC PROFILE   (FIGURE 4) OF STANDARD GUGGULSTERONE 
MIXTURE 
 
Chromatogram of standard guggulsterone mixture (1000ng/spot); peak 1is  
of  E-guggulsterone (Rf:0.38 ± 0.02),peak  of Z-guggulsterone (Rf:0.46  
± 0 . 0 2 ); mob i l e  phase ; t o luene–acetone (9.0:1.0,v/v). 
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HPTLC PROFILE OF EECC LEAVES: FIGURE 5 
 
 
     TABLE  9 
HPTLC PROFILE OF C.caudata 
COMMIPHORA RF LAMBDA MAX 
  V 
BAND 
IV 
BAND 
III 
BAND 
 
II 
BAND 
I 
BAND
 0.25 233 270 329   
  0.37 240 315 424 660  
 0.40 240 315 424 660  
 0.45 240 315 424 660  
 0.50 240 306 370 413 660 
 
 
S.NO COMPOUND RF VALUE AMOUNT PRESENT 
1 E-Guggulsterone 0.38  ±  0.02            0.051%w/w  
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STRUCTURE  OF  E - GUGGULSTERONE 
 
 
STRUCTURE  OF  Z-GUGGULSTERONE 
 
5.2.6 DETERMINATION OF TRACE ELEMENTS IN THE LEAF OF 
C.caudata BY ENERGY DISPERSIVE X-RAY SPECTROMETER (EDS) 
FIGURE – 6 
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ENERGY DISPERSIVE X-RAY SPECTRUM  FOR C.caudata LEAVES 
Estimation of the elements like Ca, O, Al and Si showed the 
following mg weight percentage and atomic percentage. 
Table-9 
C.caudata LEAVES ELEMENTS WEIGHT & ATOMIC PERCENTAGE 
Element Weight% Atomic% 
C   K 61.16 68.63 
O   K 35.85 30.20 
Na  K 0.11 0.06 
Mg  K 0.48 0.27 
Si    K 0.14 0.07 
S    K 0.10 0.04 
Cl   K 0.53 0.20 
K    K 0.36 0.12 
Ca  K 1.05 0.35 
Zn  K 0.22 0.05 
Totals 100.00  
 
PHARMACOLOGICAL  STUDIES 
5.3.1 WHOLE EMBRYO CULTURE TOXICITYSTUDY 
Effect of EECCL on the developmental stages of Zf embryo was 
carried out. The eggs were cultured in the embryonic medium. The maximal 
acceptable toxicant concentration (MATC) was calculated by scoring the 
malformation 1 % DMSO and podophyllotoxic (0.010µg/ml) were used as 
control and standard toxin. No malformations are incidence of mortality was 
observed up to the 0.5 – 1µg/ml concentration level (score 0). But medium to 
strong edema, eye malformation, bent tail, weak undulated notochord and 
twisted notochord were observed from 1 to 2 µg/ml concentration up to 80 
hpf. No mortality was observed in this concentration level. Total mortality 
was observed in the standard podophyllotoxin at 0.01µg/ml concentration 
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(score40). 
TABLE 11 
SCORES FOR THE WHOLE EMBRYO TOXICITY 
Conc. µg/ml Hours score 
0.5 – 0.7 All Nil 
1 
12 1 
36 1 
60 2 
80 2 
2 
12 5 
36 5 
60 10 
80 13 
 
5.3.2 ZEBRA FISH LARVAL TOXICITY STUDY 
Larval toxicity study was carried out on zf larvae of 5 dpf cultured in 
E3 embryonic medium. Five larvae per group was taken and treated with 
0.5, 0.75, 1 and 2 µg was taken as a test trail and mortality percentage was 
calculated. 
From the experiment it was observed that there was no mortality in 
0.5 and 0.75µg/ml concentrations. But 5% and 10% mortality was observed 
at 1 and 2 µg/ml concentrations respectively. No mortality was observed in 
the control. 100% mortality was observed in the standard podophyllotoxin 
at 0.5 µg/ml concentration. 
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TABLE 12 
ZEBRAFISH LARVAL TOXICITY STUDY 
CONCENTRATION 
(µg/ml) 
NUMBER 
OF 
LARVAE 
AFTER
24h 
CORRECTED 
MORTALITY MORTALITY 
0.5 
20 
NIL NIL NIL 20 
20 
0.75 
20 
NIL NIL NIL 20 
20 
1 
20 NIL NIL 
5 20 NIL NIL 
20 1 5 
2 
20 1 10 
10 20 1 10 
20 NIL NIL 
Control (vehicle) 
20 
NIL NIL 20 20 
20 NIL 
Standard 
podophyllotoxin 
20 20 100 
100 20 20 100 
20 20 100 
 
FIGURE 7 
ZEBRAFISH LARVAL TOXICITY 
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5.3.3 EFFECT OF EECCL ON DOXORUBICIN INDUCED  
CARDIOTOXICITY ON ZEBRAFISH MODEL 
TABLE 13 
DRUG %FS 
CONTROL 54 ± 1.22 
DOX 20± 1.08 
DOX +EECCL( 0.5ng) 30±1.15 
DOX+EECCL(1 ng) 41±1.04 
DOX+EECCL(1.5ng) 50±0.99 
DOX+METAPROLOL(25) 52 
 
FIGURE 8 
EFFECT OF EECCL ON DOXORUBICIN INDUCED CARDIOTOXICITY 
ON ZF LARVAE MODEL 
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CHAPTER VI 
DISCUSSION 
 
       The dissertation covers a study on widely available member of the 
family Burseraceae known  botanically  as Commiphora caudata (Wt & 
Arn)Engl.  which is commonly called as ‘Hill mango’, ‘Green Commipho-
ra’ in English and  ‘Kiluvai’ in Tamil. The leaves of C.caudata  really do not 
have any match as a cheap natural and easily available plant. It was                   
reported  that  Burseraceae which  family members have phytoconstituents 
useful in the treatment of various diseases and was also claimed that these 
plants merit detailed study which can prove useful in the discovery of lead 
compounds leading to novel and more efficacious drugs.    
         The plant Commiphora caudata  is traditionally  known to be useful 
to treat a range of ailments the most  important  being, diabetes, ulcer, diar-
rhoea, inflammations and spasms (Selvamani P et al.,2013,Deepa V S et 
al.,2009, Nisha P and Jyothi H.,2014) , various types of  ulcers (Ganesan S 
et al.,2008), rhumatalgia   (Nisha P and Jyoti  H ., 2014) , anti-inflammatory 
, mouth ulcer  and mainly used in the treatment of cuts  and wounds 
(Thomas B et al.,2014). It is also  act as astringent,  sweet,  cooling,  aph-
rodisiac,  diuretic and antidiabetic activities and  is used for fever, strangury 
, vitiated conditions of vata and pitta in siddha system of medicines. It  is a 
potential medicinal plant  has been used traditionally in the treatment of ar-
thritis,   diabetes and obesity.(Geetha K and Ganapathy S.,2013).  
It  is used in Ayurveda and Siddha traditional medicines.  
        Leaves of the plant used traditionally  to treat painful and inflammatory 
conditions (Annu W et al.,2010), wounds (Thomas B et al.,2014),  rheuma-
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talgia (Nisha P and Jyoti .,2014, Geetha K et al.,2014),  ulcers, diarrhoea  
and spasms (Geetha K et al.,2014), dysentery (Gunasekaran M ,  Bal-
asubramaniyam P.,2012),  to improve digestion and to increase appetite 
(Akhade MS et al.,2017), the seeds are  to relieve stomach ache. 
(Vikneshwaran D et al.,2008) The stem and bark are traditionally used in 
the treatment of  rheumatism, ulcers, diarrhoea and spasms.(Girija P et al., 
2017), lotion  of its  stembark is used to treat skin conditions such as impe-
tigo, eczema and shingles. (Prasad MNV et al.,2007), bark is used in the 
treatment of diarrhoea (Gunasekaran M, Balasubramaniyam P.,2012).  
           Phytochemical investigation of C.caudata showed that   a rich 
source  of steroidal compounds, etc.,(Selvamani P et al.,2013), steroids 
and triterpenoides and it was suggested as marker for this plant.(Akhade 
MS et al.,2017). 
 E-guggulsterone 0.059%. (Akhade MS et al.,2017) the main active 
principle of this plant. 
Flavanoids, glycosides, phenolics (phenols and polyphenols), tannins, 
carbohydrates (starch,reducing sugars), proteins and oleo-gum resin, alka-
loids, glycosides,  saponins , alkaloids, terpenoids, aminoacids, mucilage,  
antioxidant principles are also present in this plant. 
Pharmacological evidence reports that hepatoprotective, antidiabetic, 
antimicrobial, antibacterial and anticancer activities.(Selvamani P et al.,2013, 
Annu w et al.,2010, Girija P et al.,2017,etc.,),analgesic, anti inflammato-
ry(Selvamani P et al.,2013) and antioxidant (Annu w et al.,2010 ), diuretic, 
antiulcer and antibacterial activities were reported from this plant (Geetha K 
and Ganapathy S.,2013) , nitric oxide scavenging, free radical scavenging  
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(Deepa V S et al.,2009),  antimalarial (Prasad M N V et al.,2007), antiarthritic 
(Girija P et al., 2014, Reddy J S et al., 2014) ,  antihyperlipidaemic(Geetha K 
and Ganapathy S.,2013 ,Geetha K et.al,2014), antianaemic (Girija P et.al, 
2017), Cardioprotective,  gastroprotective  and anti-ulcerogenic  and is used 
for wound healing  hyperlipidemia, rheumatic disorders, obesity and is-
chaemic heart diseases.  (Geetha K et al,2014). 
PHARMACOGNOSTICAL STUDIES: 
Morphological and micromorphological examination and characteriza-
tion of medicinal plants have always been accorded due to credentials in the 
pharmacological studies. There was no detailed pharmacognostical work 
has been carried out including botanical identity based on micro morphology 
in this leaves of this plant. 
The application of morphological studies in drug analysis is pertinent 
in the field of crude drug authentication. It was studied for the leaf, Interpre-
tation of the morphological characteristics based on different parameters, for 
the plant organs give a guideline for the diagnosis of the original plant and 
its adulterants. 
Colour, size, shape, margin, texture, arrangement were observed and 
compared with previous data. 
Microscopic techniques help to magnify the fine structure of minute ob-
jects and there by confirm the structural details of the plant drug. Though the 
microscopical evaluation cannot provide complete profile, still it can offer 
supporting evidences which when combined with other analytical parameters 
can be used to obtain full evidence for standardization and evaluation of 
herbal drugs. Consideration must therefore be given to the types of cells and 
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cell inclusions and the manner in which they are distributed in different organ 
of the plants. The habit and habitat and the various morphological characters 
of the various parts have been studied after proper identification and authen-
tication. 
PHARMACOGNOSTICAL STUDIES  
                 Macroscopy of the leaves were compound, alternative 3 to 7                 
foliolate, upper surface  dark green, lower surface light green in colour. 
There is   mango like  odour and it has mucilaginous taste. Shape is ovate -
oblong, length - 4.5 to 6.5 cm; width -2.2 to 3.5 cm; acuminate apex , slight-
ly asymmetric base;  entire margin,  reticulate pinnate venation; pedicle 
length - 3.5 to 6.2 cm and glabrous texture , glossy above, subglaucous  
below. Leaflets  ovate or elliptical, chartaceous  and glabrous. 
                Microscopy of the leaves The leaflets  were dorsiventral with 
prominent midrib. Vascular bundles of the midrib include one larger medi-
an bundle and one smaller, adaxial accessory bundle. Lamina with 
uniserrate epidermal layers; mesophyll differentiated into a single layer of 
palisade cells and lobed aerenchymatous spongy parenchyma cells. Vas-
cular bundle of the lateral vein  has adaxial bundle sheath extension.             
Stomata actinocytic type; epidermal cells angular, straight and thick 
walled.Vein islets polygonal; vein termination branched many times. The 
petiole is roughly circular in outline , petiole semicircular with adaxial               
depression. Vascular strengths of the petiole many, arranged in a circle 
with adaxial opening. Petiole circular with a ring of vascular strands.            
Secretory canals occur in the phloem region of leaf, veins and petioles. 
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Large druses of calcium oxalate crystals abundant in the leaf. The fibres 
are arranged around the mucilage cells and vascular bundles. 
 Scanning Electron Microscopy (SEM): 
The Scanning Electron Microscopy with its relatively highly resolu-
tion and great depth of focus, provide topographical and morphological in-
formation. SEM studies showed the unicellular trichome and its occurrence 
and arrangement.  
Actinocytic stomata was predominantly observed. 
The plant drugs are generally used in the powdered form where the 
macro morphology is generally destroyed, so the diagnosis of the plant 
through the microscopicalcharacter is essential. The powdered crude drugs 
can be identified based on the presence or absence of different celltypes. 
In powdered microscopy observed actinocytic stomata, wavy walled 
epidermal cells, spiral annular vessels, phloem cells, sieve tube and com-
panion cells, fibres, lobed spongy parenchyma cells. 
Quantitative microscopy includes certain measurements to distin-
guish some closely related species which are not easily differentiated by 
general microscopy. The stomatal number is the oldest technique but a 
simple method of diagnosis of fragmentary leaf parts. The stomatal index 
is the percentage of stomata in relation to the epidermal cells. Both are 
very specific criteria for the identification and characterization of leafy 
drugs. Vein islet and vein termination number are another simple tech-
nique for distinguishing fragmentary specimens at specific levels. It is used 
as the distinguishing character for the leaf of the same species or different 
one (Table 1). The ash content of the crude drug is generally taken to be 
the residue remaining after incineration.  If usually represents the inorganic 
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salts naturally occurring  in  the  drug and adhering to it, but it may also in-
volve the inorganic matter added for the purpose of  adulteration. There is a 
considerable difference within narrow limits in the case of individual drug. 
Hence ash determination furnishes a basis for judging the identity and 
cleanliness of a drug and gives information related to its adulteration with 
inorganic matter. The ash or residue yielded by an organic chemical com-
pound is a rule to measure the amount of inorganic matter, which is present 
as impurity. In most cases the inorganic matter is present  in small amounts 
which are difficult to remove in the purification process and which are not 
objectionable if only traces are present. Ash values are helpful in determin-
ing the quality and purity of the crude drug in especially in powdered from. 
The acid insoluble ash is of more value to detect the earthy matter adher-
ing to the drug. In this way one can obtain evidence of the presence of for-
eign matter, which likely to occur with root, rhizomes and also in pubescent 
leaves. The water soluble ash is used to detect the presence of matter 
exhausted by water. Insufficient drying favours spoilage by molds and bac-
teria and makes possible the enzymatic destruction of activeprinciples. 
Extractive values of crude drugs determine the amount of active 
constituents in a given amount of medicinal plant material when exhausted 
with solvents. It is employed for that material for which no chemical or              
biological assay method exist. As mentioned in different official books 
[Anonymous,1996 and Horborne JB,1973] the determination of                  
water-soluble and alcohol soluble extractive, is used as means of evaluat-
ing crude drugs which are not readily estimated by other means. The ex-
traction of any crude  with a particular solvent yields a solution containing 
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different phytoconstituents. The composition of these phytoconstituents in 
that particular solvent depends upon the nature of the drug and solvent 
used. The use of single solvent can be the means of providing preliminary 
information on the quality of a particular drug sample. The water soluble 
extractive values play an important role for the evaluation of crude drugs. 
It can be used to indicate poor quality, adulteration with any unwanted ma-
terial or incorrect processing of the crude drug during the drying, storage 
etc. The alcohol soluble extractive is also indicative for the same purpose 
as water soluble extractive values (Table-6). 
Loss on drying at 105°C is determined as the presence of excess 
moisture is conductive to the promotion of mold and bacterial growth, and 
subsequently to deterioration and spoilage of the drug. 
THE  PHYTOCHEMICAL STUDIES : 
The preliminary phytochemical screening reveals the presence 
of carbohydrates, proteins and amino acids, steroids, phytosterols, mu-
cilage , alkaloids, flavonoids,  terpenoids, tannins, saponins, sterols. 
Fixed oil  and volatile oil was found to be absent.  
           The reaction of drugs in powdered form in ordinary light and with 
filtered UV light is of importance in several cases by the luminosity in 
UV light by fluorescent analysis. Many flavonoids showed distinctive 
colours under UV light. 
  Hence this parameter can also be used as a diagnostic tool for 
the standardization of herbal drugs for the detection of adulterants in 
crude drugs  (Horborne JB., 1973). 
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               The  total flavonoid content was found to be 7.8 mg/g  and  the to-
tal phenolic content was found to be 18.8 mg/g . 
Identification of inorganic minerals of the leaves of C.caudata by en-
ergy dispersive X- ray spectrometer (EDS) showed the presence of                    
C (61.16), O (35.85), Na (0.11), Mg(0.48), Si (0.14), S(0.14), Cl(0.53), 
K(0.36), Ca(1.05), Zn(0.22). 
            HPTLC analysis of EECCL was performed and the presence of E 
and Z guggulsterones and also 17, 20 dihydroguggulsterone  were identi-
fied and quantified as 0.051 % w/w. Previous studies on composition of  
EECCL  are the same mentioned above. 
PHARMACOLOGICAL STUDIES:  
 Previous acute toxicity study revealed that mortality was not observed by 
the dose of 2 g/kg  body weight  of  C.caudata  leaves  in the oral toxicity 
studies. From the results the efficiency test drug doses of 0.2,0.4g/kg  
body weight  were chosen for the efficiency studies.(Girija P et.al,2017) 
WHOLE EMBRYO CULTURE TOXICITY STUDY 
Effect of  EECCL  on the developmental stages of Zf embryo was 
carried out. The eggs were cultured in the embryonic medium. The maxi-
mal acceptable toxicant concentration (MATC) was calculated by scoring 
the malformation. 1 % DMSO and podophyllotoxin (0.010µg/ml) were used 
as control and standard toxin. No malformations or incidence of mortality 
was observed up to the 0.5 – 1µl/ml concentration level (score 0). But             
medium to strong edema, eye malformation, bent tail, weak undulated                
notochord and twisted notochord were observed from 1 to 2 µl/ml               
concentration up to 80 hpf. No mortality was observed in this concentration 
level. Total mortality was observed in the standard podophyllotoxin at 
0.01µg/ml concentration (score40). 
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ZEBRA FISH LARVAL TOXICITY STUDY 
Larval toxicity study was carried out on zf larvae of 5 dpf cultured in 
E3 embryonic medium. Five larvae per group was taken and treated with 
0.5, 0.75, 1 and 2 µl was taken as a test trail and mortality percentage was 
calculated. 
From the experiment it was observed that there was no mortality in 
0.5 and 0.75µl/ml concentrations. But 5% and 10% mortality was observed 
at 1 and 2 µl/ml concentrations respectively. No mortality was observed in 
the control. 100% mortality was observed in the standard podophyllotoxin 
at 0.5 µl/ml concentration. 
EFFECT OF EECCL ON DOXORUBICINORUBICIN INDUCED CARDIO-
TOXICITY ON ZEBRAFISH MODEL 
Zebrafish embryos 1 dpf were treated with DMSO(vehicle control), 
doxorubicin, doxorubicin + EECCL(0.5 ng, 1ng, 1.5ng) and doxorubicin + 
Metaprolol for 2 days and % of Fractional shortening was found to be 54%, 
20%, 30%, 41%, 50% and 52%  respectively. The fig 6  shows the effect of 
EECCL  to overcome doxorubicin induced decreases in cardiac contraction 
and circulation is dose dependant. From the measurement of fractional 
shortening, the suppressive effect of EECCL on doxorubicin induced              
cardiotoxicity was proved. Various clinical parameters like cardiac                    
contractility, heartbeat, pericardial edema and blood flow in tail blood ves-
sels were analysed using high speed video microscopy and found to be 
normal in test and standard. The results were found to be statistically signif-
icant and p < 0.001. 
Previous investigation revealed that E-guggulsterone  inhibited plate-
let aggregation and protected against myocardial  ischemia induced by iso-
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preternol , further suggested as this activity may be due to antioxidant prop-
erty ( Chander R et al., 2003). In another study it was concluded that  
EECCL has significant antihyperlipidemic properties and can be used in the 
treatment of vascular disorders including cardio vascular disorders like ath-
erosclerosis . The potential activity of the extracts can be attributed to the 
presence of antioxidant principles such as phenolic compounds which were 
reported from the plant (Kodali G and Seru G 2013).  
Before clinical use of EECCL identified in our screen, further experi-
ments are needed to test different routes of administration, document any 
long – term toxicities, and confirm efficacy in preventing the development of 
cardiomyopathy. More detailed characterization of the mechanism mediated 
cardioprotection may facilitate the role of the pathway screening performed 
in Zf embryos to identify novel therapies for doxorubicin induced               
cardiotoxicity.  
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CHAPTER VII 
CONCLUSION 
 
  The present investigation highlights the pharmacognostical, 
phytochemical studies of the leaves of Commiphora caudata (Wt & Arn) 
Engl. (Family:Burseraceae) and Invivo cardioprotective potential of its 
ethanolic extract on doxorubicin induced cardiotoxicity in zebrafish larvae 
model. 
It is commonly called as “Hill mango”in English and “Kiluvai” in 
Tamil, widely cheap and easily available plant. Ethnomedical information 
revealed that it is used in various ailments for long period of time. The 
tremendous economic potentiality of this cash crop remains neglected by the 
scientists, technologists, physician, traders, administrators, policy makers, 
farmers etc. 
          The morphological evaluation showed the adherence of general 
characters to the family.  Leaf is  dorsiventral in nature. 
Detailed microscopical characters of the leaves showed the presence 
of  the  mucilage cells  of the midrib. Palisade tissue is not continuous over 
the midrib region. The ground tissue is made up of closely arranged round to 
oval parenchyma cells. T.S. of Lamina showed  Adaxial epidermal cells are 
angular, straight and thick walled covered by a thick cuticle, mesophyll is 
differentiated in to palisade tissue occur beneath the epidermis as single 
layered, columnar and closely arranged cells and lobed aerenchymatous 
spongy parenchyma cells. 
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A noteworthy feature is the presence of secretory cavities lined with 
epithelium cells of the leaf and one larger median bundle and one smaller 
adaxial accessory bundle. Secretory cavities occurs below the phloem 
region. Stomata: Stomata are actinocytic. 
              Transverse section of petiole is nearly circular in outline and epidermis 
is  covered by a thick cuticle. The inner region is composed of ring of vascular 
bundle to 12 layers of parenchyma cells. Secretory canals  situated  below 
the epidermis in the cortical region.  
Scanning Electron Microscopic (SEM) observation SEM study of leaf 
provides detailed surface information and it showed the presence of few 
unicellular trichomes. 
Quantitative parameters, Vein islet and termination numbers, stomatal 
number, stomatal index, palisade ratio, loss on drying, ash values, extractive 
values were determined and presented. 
Preliminary phytochemical screening showed the presence of 
carbohydrates, proteins and amino acids, flavonoids, saponins, tannins, 
terpenoids, phytosterol, mucilage and absence of alkaloids,volatile oil, fixed 
oil. 
Quantitative inorganic elemental analysis by Energy dispersive X-Ray 
analysis (EDS) showed the presence of C (61.16), O (35.85), Na (0.11), Mg 
(0.48), Si (0.14), S (0.10), Cl (0.53),K (0.36), Ca(1.05) and Zn (0.22). 
The pharmacologically important phytoconstituents polyphenols as 
total phenolic 7.8mg/g content and flavonoids 18.8 mg/g were determined. 
The TLC and HPTLC profile of EECCL was presented. It showed the 
presence of some pharmacologically active important component is                       
E -Guggulsterones as 0.051%w/w. 
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The 3R’s ethical principle (Reduction, Refinement andReplacement) 
was implemented that help to minimize harms to vertebrate animals used in 
science. 
In our investigation we used Zebrafish larvae, which is emerging novel 
preclinical in vivo model that support rapid decision making in the early 
phases of drug discovery process. It is amendable to medium to high 
throughput screening (HTS) because of numerous advantages. The 
properties of the genome of zf have established it as an excellent model 
system that is relevant to studies of human diseases. 
We performed preliminary toxicological studies of EECCL on the 
embryo and  larvae of zebrafish and found no pronounced retardation in Zf 
embryo development when exposed to normal concentration (0.5 to 2 ng/ml) 
which showed that EECCL of leaf would  propose no hazard to early life 
stages of Danio rerio but standard toxin podophyllotoxin showed 100% 
mortality at 0.01 µg/ml. 
Larval toxicity was carried out on Zf larvae of 5 dpf, it was observed 
that there was no mortality in 0.5µg and 0.75 µg/ml concentrations. 5, 10, 
100% mortalities were observed in 1, 2 ng/ml of EECCL and 0.5 µg/ml of  
podophyllotoxin  respectively. (Previous investigation on acute toxicological 
study using EECCL showed no mortality up to 2g/kg in rats.)  
EECCL prevented the overt morphological effects of doxorubicin on 
the heart including ventricular collapse and pericardial edema. Further it 
completely rescued cardiac contractility as measured by fractional shortening 
and potently protected the heart from toxic effects of doxorubicin dose 
dependently. 
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This may be due to the presence of gugulsterone which possesses 
cardioprotective activity, 
This result is supporting the previous report of protection of EECCL in 
cardiovascular diseases like atherosclerosis 
The leaves of C.caudata may be further investigated for the 
development as novel nontoxic preventive/treatment interventions for life 
threatening cardiovascular diseases. But to confirm our findings further 
investigations of these effects to mammalian model is necessary. Further 
pharmacokinetic studies are also required to understand the post metabolism 
ingredients along with the clinical efficacy and safety in human. 
E-Guggulsterone is   the bioactive constituents of EECCL and are                   
endowed with immense pharmacological value. These conclusions could open 
a new window on the use of this plant in Ayurveda. This review clearly 
authenticates   the    Sanskrit definition of the term “guggul” which means one 
that protects against diseases. It is superbly reflected and proved by the 
diverse medicinal uses of this herbal drug. 
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